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ASSESSING SOCIAL MOTIVATIONS DURING VACCINATION DECISIONS 
Alex Joseph Francisco, Candidate for the Doctor of Philosophy Degree 
University of Missouri-Kansas City, 2018 
ABSTRACT 
This dissertation utilized two separate studies to investigate the effects of social 
motivation during vaccine decision-making. Some parents cite social motivations, like 
contributing to herd immunity, as an influence on vaccine decisions, but differences in social 
motivation between parents who are confident and those who are hesitant about vaccines has 
yet to be investigated.  Results from our first investigation among both vaccine confident and 
hesitant participants show decreased willingness to risk side effects to prevent disease in 
socially distant individuals. In vaccine hesitant individuals, empathic concern was associated 
with increased willingness to risk side effects to prevent disease in socially distant 
individuals. In vaccine confident participants, personal distress during prosocial scenarios 
was associated with decreased willingness to risk side effects in socially distant individuals. 
Shared decision making and educational programs that emphasizing empathic concern may 
increase the likelihood that hesitant individuals will vaccinate their children to protect 
socially distant individuals.  
Our second investigation focused on the primary drivers during social vaccination 
decisions. Certain vaccines carry an unbalanced ratio of risk and benefit to the individual 
being vaccinated. Symptoms of the flu, and potential side effects from the vaccine, are 
relatively low in cost to a younger individual, but can be deadly to an immunocompromised 
person. Thus, vaccinating in some cases may have more of a benefit to socially distant 
	 iv 
individuals. Results from our second study show that as benefits of the vaccine shifted to 
socially distant individuals, the influence of risk on decision making increased. This increase 
was seen in both vaccine hesitant and vaccine confident participants. Confident participants 
valued benefits equally across social distance, while hesitant participants showed an 
increased influence of benefits for socially proximate recipients. Together these results 
suggest targeting benefits to socially proximate individuals, while downplaying risks, may be 
the best strategy for increasing overall vaccine uptake.
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CHAPTER 1 
PAPER ONE 
Vaccine Hesitancy and Social Motivation During Vaccination Decisions 
Background: While some parents claim herd immunity to be an influence on vaccination 
decision making, investigations into how social motivation differs between vaccine confident 
and vaccine hesitant individuals has not yet been examined. 
 
Objective: This study aimed to investigate differences in social motivations during vaccine 
decisions between individuals hesitant and confident in vaccine efficacy. Further, it aims to 
highlight how prosocial tendencies may relate to socially motivated vaccine decisions.  
 
Methods: 41 vaccine hesitant and 49 vaccine confident participants were recruited from 
Amazon mTurk. Participants were asked to complete a series of hypothetical vaccination 
decisions including willingness to vaccinate their child to protect individuals in their social 
network from contracting a disease. Average willingness to risk side effects was calculated 
for each social distance. Methods were repeated for two levels of side effect severity. 
Measures of prosocial behavior and social network size were also collected.  
 
Results: Both vaccine confident and vaccine hesitant participants show decreased 
willingness to risk side effects to prevent disease in socially distant individuals. In vaccine 
hesitant individuals, empathic concern was associated with increased willingness to risk side 
effects (r = .33, p < .05); in vaccine confident participants, personal distress was associated 
with decreased willingness to risk side effects (r = -.39, p < .01). 
 
Conclusions: Overall willingness to vaccinate declines when considering benefits to socially 
distant people. Vaccine hesitant individuals indicate overall lower willingness to risk side 
effects, regardless of social distance. Shared decision making and educational programs that 
emphasize empathic concern may increase the likelihood that hesitant individuals will 
vaccinate their children to protect socially distant individuals.  
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Introduction 
There are a wide variety of factors that influence vaccine decision making. Potential 
barriers to vaccination include monetary costs, potential risk of side effects, and inability to 
access proper medical care. (Henininger, 2009). The most salient benefit is individual disease 
prevention. In addition, there are many benefits outside of an individual, including protection 
conferred to family members, co-workers, and members of the broader community. 
Furthermore, motivations for and against vaccination change and adapt with environmental 
circumstances, like the level of vaccination in a given population, pro and anti-vaccine 
advocacy campaigns, and the presence of disease outbreaks (Bauch & Earn, 2004; Chapman 
et al., 2012; Ehreth, 2003; Francis, Jr, Salk, & Brace, 1946; Henininger, 2009).   
Herd immunity deserves special consideration when patients make vaccine decisions. 
The notion that unvaccinated individuals can gain indirect immunity from sufficient 
vaccination levels drives the concept of herd immunity. Herd immunity extends the efficacy 
of vaccines to those who are unable to undergo vaccination themselves due to age or health-
related conditions (Fine, 1993). The necessary rates of vaccination to confer herd immunity 
can range from 80% to 99%, depending upon disease type and population level (Plans-Rubio, 
2012). Despite the importance of herd immunity for protecting the most vulnerable of our 
citizens, fewer than 6% of parents spontaneously mention the concept when describing their 
main motivations for vaccination (Quadri-Sheriff et al., 2012). Research examining the role 
of herd immunity on vaccine decisions is limited and those studies that have attempted to 
quantify or otherwise assess how herd immunity may impact vaccination decisions show 
mixed results (Quadri-Sheriff et al., 2012).  
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While parents rarely consider herd immunity as a primary reason to vaccinate their 
children, more than one-third rank herd immunity the second most important motivating 
factor driving vaccination (Quadri-Sheriff et al., 2012). With certain vaccine preventable 
diseases, this second level of motivation might prove essential. In some instances, there is a 
clear distinction between people who benefit most from vaccination, and people who are able 
to receive the vaccine. When making a decision for or against vaccinating, especially when 
the disease in question is not particularly risky to the recipient of the vaccine, it may be 
beneficial to promote prosocial motivation to increase vaccine uptake (Jordan et al., 2006; 
Reichert et al., 2001). Indeed, recent research suggests this to be the case. Li, Taylor, Atkins, 
Chapman, and Galvani (2016) showed that a short prompt showcasing societal benefits of 
vaccination increases vaccine uptake on average by between 4% to 7%. This effect was 
strongest among individuals who were historically non-vaccinators. Another contributing 
factor in this shift was an individual’s underlying prosocial tendencies, which accounted for a 
small and independent increase in people’s desire to vaccinate after receiving messages 
regarding potential benefits to others (Li et al., 2016).  
Underlying much of a decision to vaccinate is an analysis of the risks related to 
vaccines, compared against the benefits derived from vaccination and the immunity it may 
confer (Heininger et al., 2012; Henininger, 2009). However, as outlined with the principle of 
herd immunity, many of the benefits derived from vaccination actually take place beyond the 
person being vaccinated. Research has suggested that some indirect benefits can be seen 
within the family and also that individuals consider benefits to those well outside of family 
(Chapman et al., 2012; Reichert et al., 2001; Shim, Chapman, Townsend, & Galvani, 2012; 
Vietri, Li, Galvani, & Chapman, 2012). However, it follows logically that individuals may 
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care more about the indirect protection vaccines can provide among those socially close to 
them (e.g., parent) relative to those socially distant (e.g., acquaintance).  
The amount of value a person places on the indirect protection vaccines confer may 
be something that decreases with social distance. As individuals, we tend to care more about 
people socially proximate to us compared to people socially distant (Dawes, 1980; Jones & 
Rachlin, 2006; Jones & Rachlin, 2009; Rachlin & Jones, 2008a, 2008b; Trope & Liberman, 
2010). Logically, as we become less familiar with the individual receiving a reward, we 
begin to place less and less value upon the reward, until the recipient is a complete stranger.  
Recently, Jarmolowicz et al. (2018) investigated the social distance function during 
vaccination decision making. Their results support that, in general, our willingness to 
vaccinate decreases when considering benefits of vaccinating in order to protect socially 
distant individuals. In vaccine decisions, there is a small risk (perceived or actual) of 
vaccination side effects, along with benefits to oneself (immunity) and benefits to others 
(conferred immunity). An important distinction here is that there is a degree of non-
reciprocal altruism occurring – the protection conferred from vaccinating oneself or one’s 
child to socially distant individuals is not directly reciprocated in a visible manner. It has 
been suggested that this non-reciprocal altruism is related to the hyperbolic discounting of 
social benefits (Takahashi et al., 2003). The construct may apply in vaccine decisions as well 
– by vaccinating your children you may see the benefits to your family or friends, but not to 
strangers.  
By investigating changes in willingness to risk side effects from a vaccine when 
considering benefits that increase in social distance, it is possible to estimate precisely when 
the motivation to protect socially distant individuals stops. The question remains, however, 
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whether or not vaccine confidence plays a role in how people consider social distance and 
herd immunity when making vaccine decisions. Similarly, vaccine decisions involving 
socially distant benefits might be driven by different motivations. We investigated these 
questions by looking for differences in social motivations, i.e. willingness to risk side effects 
in their child, to prevent disease in socially distant individuals. Social motivations during 
vaccination decisions were compared between those hesitant of vaccines and those confident 
in the benefits of vaccines. Specifically, we hypothesized that vaccine confident and vaccine 
hesitant individuals would differ in their willingness to vaccinate, with hesitant expressing 
overall lower willingness. Next, we hypothesized that willingness to vaccinate would 
decrease when considering benefits to socially distant individuals. Finally, we hypothesized 
that prosocial tendencies would be associated with increased willingness to vaccinate in order 
to protect socially distant individuals.  
Methods 
Participants 
Participants were recruited via Amazon Mechanical Turk (mTurk) online services 
(www.mturk.com), similar to our previous study (Jarmolowicz et al., 2018). Participants 
through the mTurk service were routed to a SurveyMonkey page (www.surveymonkey.com) 
that contained the vaccine paradigm and self-report measures described in subsequent 
sections. All study procedures were approved by the University of Missouri – Kansas City 
IRB. Participants were excluded if they failed to complete all sections of our paradigm and 
self-report measures, and were paid $10 for study completion.  
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Paradigm 
Participants were presented with a series of questions asking them to indicate the 
highest likelihood of side effects they would be willing to subject their child to, given varied 
likelihoods of disease prevention. If participants did not have a child, they were asked to 
imagine making this decision for their future child. To increase the generalizability of the 
paradigm and avoid social stigmas that can be associated with certain vaccines (e.g. HPV and 
sexual activity) a specific disease was not indicated. Before beginning the paradigm, 
participants were shown a brief description and definition of what vaccines are, which reads 
as follows: 
A vaccine is defined here as a product that stimulates a person’s immune 
system to produce immunity to a specific disease, protecting the person from 
that disease. Vaccines are usually administered through needle injections, but 
can also be administered by mouth or sprayed into the nose. 
Vaccines are used to prevent specific diseases from occurring. Vaccines have 
been demonstrated to prevent diseases like Measles, Mumps, and Rubella, as 
well as cervical cancer caused by HPV, and even the seasonal flu. Vaccinating 
your child can prevent them from contracting one of these diseases. 
Vaccinating your child can also benefit the community. Vaccinating your 
child against various infections can prevent them from contracting disease, 
which also stops the disease from spreading to others.  
Some individuals are unable to receive vaccines themselves, which leaves 
them susceptible to infections that can be prevented in other individuals by 
using vaccinations. 
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To help establish the format and provide practice, three example questions were 
included in the instruction set, which presented a hypothetical participant who indicates her 
willingness to risk side effects for three levels of disease prevention. Participants were asked 
to mark the response that corresponds with the hypothetical participant’s choices. Questions 
for the paradigm presented participants with a given vaccine efficacy, and asked them to 
indicate the highest risk of side effects they were willing to subject their child to for the given 
probability of disease prevention. Each question had the same array of 15 potential responses 
that correspond with increasing risk likelihood, ranging from 0 to 99%. For ease of 
interpretation, and to be consistent with CDC presentation of side effect likelihoods, options 
were presented as “1 out of 1000.” Figure 1 illustrates the format that questions and options 
were presented to each participant for mild side effects. These same 12 questions were then 
repeated for a second level of side effect severity (indicated as moderate-to-severe). The 
particular side effects that constituted the two side effect severities were collected from the 
CDC website (CDC, 2015). Example possible mild side effects included headache, nausea, 
and bruising. Example possible moderate/severe side effects included pneumonia, severe 
pain and bleeding, and coma. 
Social Distance 
Adapting a procedure from Jones and Rachlin (2006), the paradigm incorporated a 
method to establish how motivation to vaccinate changes when considering individuals 
socially distant to the participant. To assess these factors, the paradigm asked participants to 
imagine all of their friends, relatives, and acquaintances into a quantifiable social network, in 
which they rank these individuals on a scale from 1-100. In this method, a rank of 1 is given 
to their closest, most socially proximal person (spouse, parent, best friend, etc.), and “person 
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100” represents an absolute stranger. Multiple individuals can inhabit the same ranking, but 
participants were asked to specify particular individuals (and their specific relation to the 
participant) for ranks of 3, 5, 10, and 20. The exercise of naming all of these individuals aims 
to help the participant understand the concept of social distance – our study focused on 
individuals at distances of 1 (child), 5, 20, 50, and 100.  
When making the vaccine decisions, participants were told that by vaccinating their 
child, they have the opportunity to prevent others from contracting disease as well. In order 
to assess motivation, or willingness, to prevent others from contracting a disease by 
vaccinating their children, questions asked how willing they were to risk side effects from a 
vaccine in their child (or future child), in order to protect an individual in their social network 
from contracting a disease. For questions assessing willingness to prevent disease in persons 
5 and 20, the particular name each participant used when outlining their social network was 
imported into the questionnaire. For persons 50 and 100, because these were assumed to be 
unnamed acquaintances, “Person 50” and “Person 100” were used in place of names. 
Additionally, following the format from Strombach et al., (2015), a diagram was employed to 
visualize all 100 individuals in their social network (see Figure 1).  
In the full paradigm, participants were first asked how willing they are to risk side 
effects to their child, in order to prevent disease in their child. Following that, they were 
asked to indicate how willing they are to risk vaccine side effects in their child, in order to 
prevent disease in particular members of their social network. The same 12 levels of vaccine 
efficacy and 15 options of risk were repeated across each level of social distance considering 
risk of mild side effects, and then all options were repeated again for decisions involving 
moderate-to-severe side effects, for a total of 120 questions (five social distances, 12 
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questions, two levels of side effect severity). Participants were paid $10 upon full completion 
of the study. Participant responses were examined for logical accuracy (more willing to risk 
mild side effects compared to moderate/severe).  
Self-Report Measures 
Vaccination Confidence Scale (Gilkey et al., 2014). The Vaccination Confidence 
Scale (VCS) was used to split participants into those low or high in vaccine confidence. This 
scale assesses attitudes about vaccination along several metrics, with the overall levels of 
confidence. Previous research establishing the VCS showed that approximately 5% of the 
population would indicate sufficient levels of vaccine hesitancy on the VCS to score <=6 
(Gilkey et al., 2014). To gather sufficient numbers of vaccine hesitant participants, 1,200 
individuals were administered the Vaccination Confidence Scale (VCS). Of those, 72 had 
scores qualifying as vaccine hesitant. Fifty of these were then allowed to take the full 
paradigm. Participants were split along the suggested guidelines of <=6 suggesting low 
vaccine confidence, and >6 supporting medium or high vaccine confidence. Comparisons 
were made between these two groups. Previous research with the VCS has suggested that 
these groups differ fundamentally in their decision making, and should be treated as 
independent subjects (Gilkey et al., 2014).  
 Social Network Index (Cohen, Doyle, Skoner, Rabin, and Gwaltney, 1997). The 
social network index (SNI) is a 12-item scale that provides a comprehensive picture of the 
size and makeup for an individual’s social network. Two subscales, Total Social Network 
Size (SNI-S) and High Contact Roles (SNI-HC) were calculated and used to investigate 
correlations with vaccine decisions regarding socially distant individuals.  
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Prosocial Personality Battery (Penner, Fritzsche, Craiger, and Freifeld, 1995). The 
prosocial personality battery (PSB) was used to assess the prosocial tendencies of the 
participants. Subscales of the Prosocial Personality Battery (PSB) include Personal Distress 
(PSB-PD; 5 items, α = .76), the tendency to experience self-oriented feelings of personal 
anxiety and unease in tense interpersonal situations; Empathic Concern (PSB-EC; 7 items, α 
= .78), the tendency to experience other oriented feelings of sympathy and concern for 
unfortunate others; Moral Reasoning (PSB-M; 4 items, α = .63), the tendency to consider the 
best interests of all affected parties when making moral decisions; and finally Helpfulness, a 
measure of altruism (PSB-SRA; 14 items, α = .83). 
Analytic Methods 
Average willingness to vaccinate was calculated for each social distance by averaging 
the willingness to risk side effects for each stated level of vaccine efficacy within a social 
distance. Thus, this measure is specific to our stated levels of vaccine efficacy. These 
measures were then used to compare changes in willingness to vaccinate as social distance 
increases. The same measure was calculated for decisions involving mild side effects and 
moderate-to-severe side effects. An overall 5 (Social Distance) x 2 (Hesitancy Status) x 2 
(Side Effect Severity) ANOVA was run to investigate if an interaction existed across the full 
model of vaccine decisions.  
Follow up analyses investigated effects within the two side effect severities. Separate 
5 (Social Distance) x 2 (Hesitancy) ANOVAs were run for the two side effect severities, and 
further analyses examined how willingness to vaccinate differs between social distances and 
vaccine hesitancy. In our analyses, decisions considering benefits to socially distant 
individuals were treated as independent groups.  
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Finally, correlations were run using willingness to vaccinate and self-report measures 
described earlier. For these correlations, bootstrapping was performed in order to further 
assess the validity of the associations. Bootstrapping was performed for 1000 samples. The 
resulting 95% CI was assessed, and if the CI of the correlation coefficient crossed zero, the 
correlation was deemed not significant, even if the obtained p-value was below .05. Last, to 
further reduce familywise error, behavioral data were boxed into two categories – Proximate 
and Distal. Proximate decisions were comprised of Child and Person 5. Person 50 and 100 
were grouped together into Distal decisions. We hypothesized that measures of social 
network size would positively correlate with willingness to vaccinate socially distant 
individuals. Presumably, individuals with larger social networks may have a larger pool of 
potential individuals that they run the chance of spreading disease to. This increase in social 
network size may factor in to their decisions to protect those in their social networks from 
contracting a disease that they (or their children) might spread. Further, measures of 
prosocial behavior were hypothesized to correlate with willingness to vaccinate to protect 
socially distant individuals.  
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Figure 1. Example of paradigm assessing social distance effects. These questions are specific 
to vaccine decisions involving “Person 50” in the participant’s social network. 
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Results 
Demographics 
 
 Table 1 
 
 Summary of Demographics  
 
Demographics (n = 90) 
  
Age M = 36.8 SD = 10.0 
Gender 43 Female 47 Male 
Parental Status 39 Parents 51 Non-Parents 
Income Mdn = $41,500  
Vaccine Confidence Scale Hesitant = 41  Confident = 49 
   
Race N =   
Asian 8  
African-American 9  
Hispanic 9  
Multiracial 1  
Native American/Alaskan 2  
White 61  
   
Education N =  
Some high school 1  
High School/GED 12  
Some College 30  
Associates/Vocational School 6  
Bachelor’s Degree 30  
Master’s Degree 10  
Doctorate or Professional 1  
 
Table 1 outlines the relevant demographics of the included sample for the first set of 
analyses. In this sample, we initially collected 70 participants with VCS scores yielding a 
status of vaccine confident, and 50 participants deemed vaccine hesitant. Of the hesitant 
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participants, five were excluded for reverse responses (indicating less willingness to 
vaccinate with increasing vaccine efficacy,) and four were excluded for indicating greater 
willingness to risk moderate-to-severe side effects relative to mild side effects. Similarly, for 
vaccine confident participants, 18 participants were excluded for reverse responding, and 
three indicated more willingness to risk more severe side effects. Hesitant participants had a 
significantly (p = .025) higher percentage of parents (56%) compared to confident 
participants (33%), so parental status was included as a covariate in subsequent ANOVAs. 
No other significant demographic differences were observed.  
Behavioral Outcomes 
Social Distance, Hesitancy Status, and Vaccine Decisions 
The overall model, a 5 (Social Distance) x 2 (Side Effect Severity) x 2 (Hesitancy) 
repeated measures ANOVA reveals overall significant main effects for social distance [F(2.2, 
180.0), = 54.9, p < .001, ηp2 = .39] and side effect severity [F(2.2, 180.0), = 41.6, p < .001, 
ηp2 = .33]. Between subjects analyses show a significant effect of hesitancy [F(1, 87), = 8.7, p 
= .004, ηp2 = .09]. Interactions between hesitancy and social distance were significant [F(2.2, 
193.1), = 13.7, p < .001, ηp2 = .14], as well as between hesitancy and side effect severity 
[F(1, 88), = 5.64, p = .02, ηp2 = .06]. Finally, a three way interaction between social distance, 
side effect severity, and hesitancy was significant [F(2.3, 202.3), = 5.45, p = .003, ηp2 = .06]. 
Parental status did not have a significant main effect on results (p = .424). All analyses used 
Greenhouse-Gessier corrections for violations of sphericity. Figures 3-4 illustrate these data. 
The interaction depicted in Figure 4 illustrates that hesitant participants only marginally 
decrease in their willingness to risk side effects between levels of severity, particularly for 
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Figure 2. These charts show the relationship between overall willingness to vaccinate, social 
distance, and side effect severity. Both graphs depict overall willingness to vaccinate at each 
social distance, split between hesitant and confident participants. The first graph shows 
decisions involving consideration of mild side effects. The second illustrates decisions 
involving risk of Moderate-to-Severe side effects (ModSev). Error bars represent standard 
error of the mean.  
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Figure 3. This graph shows how the two groups (hesitant and confident) changed in their 
decision making when side effect severity increased from mild side effects to consideration 
of moderate-to-severe side effects. Confident participants showed greater decreases in the 
more proximate social distanced (Child, Person 5) relative to the hesitant participants, who 
showed little change with the side effect severity increase. Error bars represent standard error 
of the mean.  
 
 
 
 
 
child decisions. Confident participants show a much larger decrease in their willingness to 
risk side effects. This interaction is most likely due to the increased perception of side effect 
severity that goes along with vaccine hesitancy, reducing the overall variability in hesitant 
participants’ willingness to risk side effects.  
Differences in Social Motivation During Vaccine Decision-Making 
Independent sample t-tests were run to determine differences in overall willingness to 
vaccinate between hesitant and confident participants. Table 2 outlines the differences 
between groups at each social distance for decisions involving consideration of mild side 
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effects as well as consideration of moderate-to-severe side effects. Next, the main effects for 
social distance were examined for the separate groups and side effect severities. For hesitant 
participants, mild side effect decisions had a significant main effect of social distance [F(2.1, 
83), = 12.3, p < .001, ηp2 = .24] but no main effect for social distance during moderate-to-
severe side effect decisions [F(1.3, 83), = 2.4, p > .05]. For confident participants, a main 
effect of social distance was significant for mild side effect decisions [F(2.1, 99), = 41.8, p < 
.001, ηp2 = .47] and significant for moderate-to-severe side effect decisions [F(1.6, 77), = 
15.0, p < .001, ηp2 = .24]. To further delineate where the differences occurred with increasing 
levels of social distance, follow up paired sample t-tests were performed. Table 3 outlines 
these differences.  
These t-tests targeted each level of increase in social distance to illustrate the decline 
in willingness to vaccinate as social distance increases. Results show that hesitant 
participants decrease significantly in their willingness to vaccinate between benefits for 
person 20 and person 50, as well as between person 50 and person 100, when considering 
mild side effects. However, when considering moderate-to-severe side effects, no differences 
are seen for hesitant individuals between social distances. Confident individuals show 
decreases between all levels of social distance for Mild side effects, but only show 
differences between Child and Person 5, as well as Person 20 and Person 50 when 
considering moderate-to-severe side effects.  
Associations between Self-Report and Vaccine Decisions 
Correlations were run between decisions at each social distance and three self-report 
measures. Correlations were performed separately for hesitant and confident individuals to 
assess for potential group differences in associations between vaccine decisions and self-
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report. Table 4 outlines the correlations carried out for the two groups. For hesitant 
participants considering mild side effects, increased empathic concern was related to 
increases in willingness to risk side effects to prevent disease in socially distant individuals. 
For moderate-to-severe side effects, increased empathic concern was related to higher 
willingness to risk side effects to prevent disease in socially proximate individuals, but not 
socially distant ones. For confident participants, increases in personal distress were 
associated with decreases in willingness to risk side effects in order to prevent disease in 
socially distant individuals, specifically when considering moderate-to-severe side effects. 
		
 
 
 
Table 2. 
 
Group differences in willingness to vaccinate at each social distance 
 
 Hesitant Confident     
Mild Decisions M SD M SD t df p d 
Child 0.176 0.184 0.447 0.227 -6.14 84 <.001 -1.34 
Person 5 0.164 0.188 0.326 0.265 3.28 84 .001 -0.72 
Person 20 0.142 0.178 0.248 0.256 2.24 84 .028 -0.49 
Person 50 0.085 0.132 0.209 0.251 2.84 84 .006 -0.62 
Person 100 0.064 0.129 0.179 0.242 2.75 84 .007 -0.60 
Moderate-to-Severe Decisions         
Child 0.061 0.125 0.138 0.167 -2.43 84 .017 -0.53 
Person 5 0.049 0.122 0.101 0.159 -1.73 84 .087 -0.38 
Person 20 0.056 0.130 0.089 0.163 -1.07 84 .287 -0.23 
Person 50 0.045 0.121 0.073 0.150 -.978 84 .331 -0.21 
Person 100 0.043 0.121 0.073 0.149 -1.01 84 .314 -0.22 
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  Table 3.  
 
  Willingness to vaccinate at increasing social distances 
 
 
 
  
  
Mild Decisions     
Hesitant n=41 Mdiff t p d 
Child – Person 5 0.0118 .675 .504 0.01 
Person 5 – Person 20 0.0218 1.52 .136 0.03 
Person 20 – Person 50 0.0571 2.88 .006 0.10 
Person 50 – Person 100 0.0212 2.93 .006 0.10 
Confident n= 49     
Child – Person 5 0.1214 4.64 <.001 0.25 
Person 5 – Person 20 0.0775 4.06 <.001 0.19 
Person 20 – Person 50 0.0396 3.73 .001 0.16 
Person 50 – Person 100 0.0292 3.99 <.001 0.19 
     
Moderate-to-Severe 
Decisions     
Hesitant  t p  
Child – Person 5 0.0123 1.31 .199 0.02 
Person 5 – Person 20 -0.0070 -.987 .330 -0.01 
Person 20 – Person 50 0.0106 1.55 .129 0.03 
Person 50 – Person 100 0.0017 1.16 .253 0.02 
 
Confident     
Child – Person 5 0.0367 3.98 <.001 0.18 
Person 5 – Person 20 0.0117 1.50 .139 0.03 
Person 20 – Person 50 0.0159 3.44 .001 0.14 
Person 50 – Person 100 0.0008 .221 .682 0.00 
     
		
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Bootstrapping was performed to assess CI of correlation coefficient, reported here. Italics indicates rejected 
significant correlation due to CI crossing 0.  
*p < .05 
**p < .01 
Table 4.  
 
Pearson correlations between self-report measures and vaccine decisions 
 Hesitant n = 41 Confident n = 49 
Mild Decisions Proximate Distal Proximate Distal 
Prosocial Personality      
Empathic Concern .04 [-.32, .39] .31 [.04, .55]* .13 [-.15, .39] -.05 [-.41, .26] 
Personal Distress -.02 [-.40, .35] -.10 [-.45, .37] -.20 [-.40, .04] -.23 [-.46, .03] 
Moral Reasoning .20 [-.13, .50] .32 [-.09, .66] .10 [-.12, .33] .13 [-.21, .47] 
Self-Reported Altruism -.01 [-.30, .31] .25 [-.04, .52] .21 [-.07, .45] .08 [-.22, .34] 
Social Network Index     
Social Network Size -.18 [-.32, .39] .08 [-.21, .51] .09 [-.09, .38] .19 [-.13, .52] 
High Contact Roles -.03 [-.32, .39] .20 [-.21, .34] -.09 [-.27, .18] .00 [-.26, .35] 
 
Moderate-to-Severe Decisions     
Prosocial Personality      
Empathic Concern .33 [.05, .57]* .29 [-.02, .53] -.18 [-.51, .19] -.16 [-.54, .32] 
Personal Distress -.11 [-.46, .33] -.06 [-.44, .39] -.22 [-.43, .06] -.39 [-.54, -.16]** 
Moral Reasoning .11 [-.37, .54] .19 [-.23, .54] -.24 [-.56, .17] -.24 [-.64, .29] 
Self-Reported Altruism .20 [-.15, .49] .14 [-.09, .52] -.18 [-.42, .10] -.08 [-.36, .19] 
Social Network Index     
Social Network Size .15 [-.15, .58] .22 [-.16, .57] .30 [-.09, .62] .29 [-.20, .69] 
High Contact Roles -.05 [-.18, .37] .03 [-.17, .40] .22 [-17, .59] .18 [-.28, .61] 
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Discussion 
We used a novel approach to investigate motivations underlying vaccine decisions 
and analyzed differences in willingness to vaccinate between vaccine hesitant and vaccine 
confident individuals. By utilizing a social motivation outcome metric, we were able to 
elucidate how willingness to vaccinate may change when considering the benefits of vaccines 
to socially distant individuals. In particular, results showed that all individuals, regardless of 
hesitancy status, are less willing to risk side effects in their children to protect socially distant 
people, compared to socially close people. This decline is more pronounced in vaccine 
confident individuals, however, most likely due to the very low overall willingness displayed 
by vaccine hesitant participants. Both groups were less willing to risk more severe side 
effects, but the confident participants again show a much larger decrease with increased 
social distance. Overall, as expected, vaccine hesitant individuals showed very low 
willingness to vaccinate.  
 Examining the relationship between social motivations and vaccine decisions across 
hesitancy revealed some interesting findings. First, there are clear distinctions in willingness 
to vaccinate between social distances, even among hesitant participants. Both groups show 
higher willingness to vaccinate in order to prevent disease in socially proximate individuals, 
but the groups differ in the particular social distance where willingness to vaccinate stops 
decreasing. Considering mild side effects, hesitant participants show higher willingness to 
risk side effects in order to prevent disease in person 5 and person 20, yet do not differentiate 
between person 50 and 100. Confident individuals, in contrast, differentiate willingness to 
vaccinate at all described social distances, decreasing between each level of distance. This 
suggests that, for both groups, targeting interventions that promote herd immunity benefits at 
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a more socially proximate level (grandparents, aunts/uncles, young cousins etc.) would be 
more beneficial, as both groups maintain some willingness to risk side effects in their 
children to prevent disease in these socially closer individuals. Our findings are consistent 
with previous research showing reduced willingness to vaccinate to protect others (Bauch, 
Galvani, & Earn, 2003; Chapman et al., 2012; Galvani, Reluga, & Chapman, 2007; 
Jarmolowicz et al., 2018; Vietri et al., 2012), and can further explain the differential effects 
that vaccine hesitancy has on this relationship, in addition to specifically addressing 
differences in the recipient of the herd immunity benefits.  
Self-Report Associations 
 Self-report measures elucidating potential relationships between personality 
characteristics and willingness to vaccinate show that there may be certain attitudes that 
relate to both increases and decreases in prosocial vaccination behaviors. Particularly, 
hesitant individuals with higher levels of prosocial empathic concern may be more willing to 
vaccinate to protect socially distant individuals. However, the relationship between empathic 
concern and increased willingness for these hesitant individuals only holds for certain 
circumstances –	when side effects are mild, the relationship stays true, but when considering 
moderate-to-severe side effects, hesitant individuals with higher empathic concern are more 
likely to express higher willingness to vaccinate to protect socially proximate individuals. 
When costs to vaccinate (potential moderate-to-severe side effects) are high, the relationship 
between empathic concern and increased willingness to vaccinate disappears. This 
relationship is similar to previous research investigating prosocial motivation in vaccination 
decision-making, where individuals indicated more motivation to vaccinate when perceived 
costs to self were low (Chapman et al., 2012; Vietri et al., 2012) 
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For vaccine confident individuals, significant correlations were seen with the 
Personal Distress subscale. This subscale in particular measures the amount of distress 
someone experiences when they are expected to act in a prosocial manner. As an individual’s 
indicated level of personal distress increased, their willingness to risk moderate-to-severe 
side effects in order to prevent disease in socially distant people decreased. These individuals 
express more self-interested tendencies in scenarios where acting prosocially might involve 
high risk to themselves. Presumably, when considering moderate-to-severe side effects, the 
perceived costs of vaccination are high. As a result, even though these individuals are aware 
of, and confident in, the benefits of vaccination, they are less likely to vaccinate to protect 
socially distant individuals. Previous research has supported this finding, showing that 
increased cost can move individuals from population interest to self-interest behaviors (Shim, 
Grefensetette, Albert, Cakouros, & Burke, 2012). 
Limitations and Future Directions 
Our study had several limitations. First, these decisions were all hypothetical in 
context.  Our questions did not include a particular vaccine, but used more general language 
in an attempt to understand global vaccine attitudes. Future research could use a similar 
paradigm among people making real word vaccine decisions to assess vaccination attitudes 
for more specific vaccines, like influenza, MMR, and HPV, which may carry different 
attitudes. Further, online methods of administration may have an impact on data validity. 
However, participants were specifically filtered for quality responses through their mTurk 
worker status, and previous research using mTurk has been shown to be valid and reliable 
(Jarmolowicz et al., 2018; Keith, Tay, & Harms, 2017; Stritch, Pedersen, & Taggart, 2017). 
On a similar note, 30 participants were removed for data quality purposes. Some of this 
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poorer data quality may also be due to the online administration format. Previous research 
using these types of social distance paradigm have seen similar numbers of excluded 
participants (Jones & Rachlin, 2006; Jones & Rachlin, 2009; Rachlin & Jones, 2008b). 
Further, when including all 120 initial participants, primary outcomes of social distance (p < 
.001), side effect severity (p < .001), and hesitancy (p = .01) were still significant. The three-
way ANOVA interaction between the factors also remained significant (p < .05). This 
suggests that our results are robust.  Finally, our results for correlations were exploratory in 
nature, and should be considered as areas for future research to further investigate.  
Vaccine hesitant and vaccine confident participants were vastly different in their 
willingness to vaccinate when considering mild side effects, but had similar willingness to 
risk side effects when considering moderate-to-severe side effects. This suggests that an 
increased perception of risk may underlie the differences in willingness to vaccinate. Future 
research should aim to delineate these more precise motivations to vaccinate at each social 
distance. Furthermore, even vaccine confident participants showed decreased willingness to 
vaccinate in order to protect socially distant individuals. For certain vaccine preventable 
diseases, like influenza, the individuals most benefited from mass vaccination are those who 
cannot be vaccinated themselves, such as the elderly, the young, or immunocompromised 
people. To confer vaccine benefits to those individuals, certain vaccine confident individuals 
may have to uptake vaccines even if the perceived cost (money, time, side effects) is higher 
than the perceived benefits to themselves (Vietri et al., 2012). Our research shows that 
appealing to the empathic concern for hesitant individuals, and downplaying the personal 
distress for confident individuals, may help increase vaccine uptake to protect socially distant 
individuals in certain circumstances. Future research could aim to investigate these particular 
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ideas as methods of intervention to improve vaccine uptake or motivation to vaccinate to add 
to the herd immunity.  
Overall, our research has just begun to describe the complex motivations underlying 
vaccine decisions. Findings support the idea that vaccine hesitant individuals are lower in 
their willingness to vaccinate than vaccine confident participants. Both groups show reduced 
willingness to vaccinate their children in order to protect socially distant people, but the 
distances at which the decline in willingness to vaccinate varies dependent on hesitancy and 
side effect severity. When considering more severe side effects, and potential to prevent 
disease in socially distant persons, both hesitant and confident individuals show highly 
reduced willingness to vaccinate. Empathic concern may increase a hesitant individual’s 
willingness to vaccinate under certain circumstances, and personal distress may decrease a 
confident individual’s willingness to vaccinate.  
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CHAPTER 2 
PAPER TWO 
Influence of Side Effect Risk Increases During Prosocial Vaccine Decisions  
Abstract 
Certain vaccines carry an unbalanced ratio of risk and benefit to the individual being 
vaccinated. Symptoms of the flu, and potential side effects from the vaccine, are relatively 
low in cost to a younger individual, but can be deadly to an immunocompromised person. 
Thus, vaccinating in some cases may have more of a benefit to socially distant individuals. 
Ninety-eight individuals were assessed on a paradigm to evaluate how risk of side effects and 
vaccine efficacy influence parental vaccine decisions. As benefits of the vaccine shifted to 
socially distant individuals, the influence of risk on decision making increased. This increase 
was seen in both vaccine hesitant and vaccine confident participants. Confident participants 
valued benefits equally across social distance, while hesitant participants showed an 
increased influence of benefits for socially proximate recipients. This suggests targeting 
benefits to socially proximate individuals, while downplaying risks, may be the best strategy 
for increasing vaccine uptake. 
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Introduction 
The utility for any given vaccine has been typically defined as the difference between 
perceived benefits, and perceived costs, or risk, related to vaccination (Bauch & Earn, 2004). 
During a vaccine decision, parents consider the risk of side effects from a vaccine, the risk of 
contracting a disease, and the morbidity related to that disease. Within this calculation of risk 
is an indirect influence from other parental decisions – higher levels of vaccine uptake among 
other children reduces the likelihood that their child will contract a disease without 
subjecting them to a vaccine (Bauch & Earn, 2004; Manfredi et al., 2010). Research 
examining the impact of this herd immunity principle on vaccine decisions is decidedly 
limited and those studies that have attempted to quantify or otherwise assess how herd 
immunity may impact vaccination decisions show mixed results (Quadri-Sheriff et al., 2012).  
Although not typically considered as a primary reason to vaccinate their children, 
more than one-third of parents rank herd immunity to be the second most important feature 
of vaccination (Quadri-Sheriff et al., 2012). This secondary motivation could be considered 
more important for certain vaccine preventable diseases. Some vaccine preventable diseases,  
like influenza, have a significant distinction between those who benefit most from 
vaccination, and those who are able to receive the vaccine. The elderly and very young 
infants are typically not eligible for influenza vaccines, yet they have the highest risk of death 
from contracting the disease (Committee on Infectious Disease, 2004; Mutsch  et al., 2004). 
It may be beneficial to promote a prosocial motivation to increase vaccine uptake when 
making a decision for or against vaccinating when the disease in question is not particularly 
risky to the recipient of the vaccine, (Jordan et al., 2006; Reichert et al., 2001). 
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Li et al. (2016) suggests that a short prompt showcasing societal benefits of 
vaccination can increase vaccine uptake. Importantly, the effective increase was strongest 
among historical non-vaccinators. It could be that these individuals originally downplayed 
the risks of spreading disease, but a presentation reminding them about preventing disease in 
more vulnerable populations shifted their motivation to vaccinate towards helping others. 
Other research has investigated how prosocial messages may influence a by-product of herd 
immunity known as free-riding (Betsch, Böhm, & Korn, 2013; Heffernan & Keeling, 2009). 
When faced with increased population levels of vaccination, a dichotomy arises. The 
decreased global risk of contracting vaccine preventable diseases reduces the perception of 
disease susceptibility, thereby decreasing an individual’s motivation to vaccinate. Messages 
highlighting the individual benefits of herd immunity have been shown to promote free-
riding, while messages promoting societal benefits increased prosocial vaccination behaviors 
(Betsch et al., 2013). So long as the messaging used frames herd immunity as a population 
benefit, free-riding behavior is not increased.  
Research suggests that up to 25% of a vaccination decision may be accounted for by 
altruistic tendencies (Shim, Chapman, et al., 2012). Perhaps not surprisingly though, game 
theoretical models of vaccination behavior suggest that total disease eradication cannot be 
achieved, as certain subsets of individuals perceive vaccine risks as greater than the risk of 
infection (Bauch & Bhattacharyya, 2012; Bauch & Earn, 2004; Bauch & Galvani, 2013). 
This conflict impacts vaccine policies in the US, which currently do not enforce mandatory 
vaccination. A dilemma occurs where voluntary vaccination rates will not allow for herd 
immunity to take place, but mandatory vaccination policies may be rightly seen as a violation 
of an individual’s civil liberties (Bauch et al., 2003). As a result, there must also be a push to 
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vaccinate with population based prevention in mind, which would involve altruistic actions 
on the part of some individuals. A better understanding of the process underlying the role 
altruism plays in vaccine motivation would help to build programs that increase vaccine 
uptake to reach herd immunity levels. 
As individuals, we tend to care more about the people socially proximate to us 
compared to those socially distant (Dawes, 1980; Jones & Rachlin, 2006; Jones & Rachlin, 
2009; Rachlin & Jones, 2008a, 2008b; Trope & Liberman, 2010). Of particular interest are 
the underlying motivations driving this decrease in value. In the context of a vaccine 
decision, there may be a decrease in the perception of the benefits as we consider socially 
distant disease prevention. In addition, there may be an increased perception of the risk 
involved when considering benefits to socially distant individuals. Our previous work has 
shown that willingness to vaccinate decreases systematically when considering benefits to 
increasingly socially distant individuals (Jarmolowicz et al., 2018), but the primary 
motivators underlying this decrease are yet to be investigated. In addition, any difference in 
motivation between those confident about vaccine efficacy, and those hesitant about vaccines 
is still unknown.  
By directing our investigations towards the underlying influences on vaccine 
decisions, this study aimed to delineate the differential influence of social motivation, risk, 
and benefit during vaccine decision making. Specifically, we hypothesized that the influence 
of risk on decisions would increase when considering benefits to socially distant individuals. 
Focusing follow-up investigations on differences between vaccine hesitant and vaccine 
confident individuals, we hypothesized that hesitancy would decrease the influence of 
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benefits globally.  Finally, we hypothesized that the influence of benefits would decrease 
with increasing social distance.  
Methods 
Participants 
Participants were recruited via Amazon Mechanical Turk (mTurk) online services 
(www.mturk.com). Through mTurk, participants were directed to SurveyMonkey 
(www.surveymonkey.com) where the vaccine paradigm was administered. All study 
procedures were approved by the University of Missouri – Kansas City Institutional Review 
Board. Participants were excluded if they fail to complete all sections of our paradigm and 
self-report measures. Participants were paid $10 for full study completion.  
The Vaccination Confidence Scale (VCS) (Gilkey et al., 2014), was used to split 
participants into those low or high in vaccine confidence. This scale assesses attitudes about 
vaccination along several metrics, with overall levels of confidence. Previous research 
establishing the VCS showed that approximately 5% of the population would indicate 
sufficient levels of vaccine hesitancy on the VCS to score <=6. In order to ensure that our 
sample had sufficient numbers of vaccine hesitant participants, 1,200 individuals were 
administered the Vaccination Confidence Scale (VCS). Of those, 72 had scores qualifying as 
vaccine hesitant. Fifty of these were then allowed to take the full paradigm.  
Participants were split along the suggested guidelines of <=6 suggesting low vaccine 
confidence, and >6 supporting medium or high vaccine confidence. Comparisons were made 
between these two groups. Previous research with the VCS has suggested that these groups 
differ fundamentally in their decision making, and should be treated as independent subjects 
(Gilkey et al., 2014). 
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Paradigm 
Participants were administered a series of questions asking them to indicate the 
highest likelihood of side effects they would be willing to subject their child to, given varied 
likelihoods of disease prevention. Those participants without children were asked to imagine 
making this decision for their future child.  A specific vaccine preventable disease was not 
indicated in order to increase the generalizability of the paradigm and avoid social stigmas 
that can be associated with certain vaccines (e.g. HPV and sexual activity). Before beginning 
the paradigm, participants were shown a brief description and definition of what vaccines 
are, which reads as follows: 
A vaccine is defined here as a product that stimulates a person’s immune 
system to produce immunity to a specific disease, protecting the person from 
that disease. Vaccines are usually administered through needle injections, but 
can also be administered by mouth or sprayed into the nose. 
Vaccines are used to prevent specific diseases from occurring. Vaccines have 
been demonstrated to prevent diseases like Measles, Mumps, and Rubella, as 
well as cervical cancer caused by HPV, and even the seasonal flu. Vaccinating 
your child can prevent them from contracting one of these diseases. 
Vaccinating your child can also benefit the community. Vaccinating your 
child against various infections can prevent them from contracting disease, 
which also stops the disease from spreading to others.  
Some individuals are unable to receive vaccines themselves, which leaves 
them susceptible to infections that can be prevented in other individuals by 
using vaccinations. 
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To test and ensure an understanding of the paradigm, an initial hypothetical 
participant was presented for three example questions. In this scenario, the task was to mark 
the response that corresponds with the given hypothetical participant’s choices. Questions in 
the full paradigm presented participants with a given vaccine efficacy, and asked them to 
indicate the highest risk of side effects they are willing to subject their child to for the given 
probability of disease prevention. Each question has the same array of 15 potential responses 
that correspond with increasing risk likelihood, ranging from 0 to 99%. For ease of 
interpretation, and to be consistent with CDC presentation of side effect likelihoods, options 
were presented as “1 out of 1000.” Figure 1 illustrates the format that questions and options 
were presented to each participant for mild side effects. Example side effects were collected 
from the CDC website (CDC, 2015) with mild side effects including headache, nausea, and 
bruising.  
Social Distance 
Following the methods described in our previous work in Jarmolowicz et al. (2018), a 
social distance paradigm was used to investigate changing motivations when considering 
individuals socially distant to the participant. To assess these factors, the paradigm asked 
participants to imagine all of their friends, relatives, and acquaintances into a quantifiable 
social network, in which they rank these individuals on a scale from 1-100. In this method, a 
rank of 1 is given to their closest, most socially proximal person (spouse, parent, best friend, 
etc.), and “person 100” represents an absolute stranger. Multiple individuals can inhabit the 
same ranking, but participants were asked to specify particular individuals (and their specific 
relation to the participant) for ranks of 3, 5, 10, and 20. The exercise of naming all of these 
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individuals aimed to help the participant understand the concept of social distance – our 
study focused on individuals at distances of 1 (child), 5, 20, 50, and 100.  
When making the vaccine decisions, participants were told that by vaccinating their 
child, they have the opportunity to prevent others from contracting disease as well. In order 
to assess motivation, or willingness, to prevent others from contracting a disease by 
vaccinating their children, questions were designed by asking how willing they are to risk 
side effects from a vaccine in their child, in order to protect an individual in their social 
network from contracting a disease. For questions assessing willingness to prevent disease in 
persons 5 and 20, the particular name each participant used when outlining their social 
network was imported into the questionnaire. For persons 50 and 100, because these are 
assumed to be unnamed acquaintances, “Person 50” and “Person 100” was used in place of 
specific names.  
Because each question had the same 15 response options of side effect probabilities 
and participants were asked to indicate their highest value of acceptable side effect risk, any 
value lower than their indicated value was also considered as a “yes”. For example, if a 
participant indicates that they would accept a 25% risk of side effects they would also 
logically accept risks of 10% and 15%, as these are lower values. Following this idea, it is 
possible to code each pair of side effect risk and vaccine efficacy resulting in 15 binary 
(yes/no) responses per question. This makes a total of 180 responses within each social 
distance, for a total of 900 binary responses per participant including all five of the social 
distances which were used in logistic regressions. The beta weight values derived from these 
logistic regressions served to quantify the influence of risk and benefit on vaccination 
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decision making. Thus, the resulting beta weight values describe how risk and benefit 
influenced the decision to vaccinate at each level of social distance. 
Analytic Methods 
To investigate the separate influences that changing levels of side effect risk (risk) 
and vaccine efficacy (benefit) had on vaccine decisions, logistic regressions were used on an 
individual level for each participant. Risk and benefit were entered into the model together, 
with decision to vaccinate for each paring of side effect risk and vaccine efficacy coded as a 
binary outcome (yes/no). Results yielded individual beta weights for the influence of 
increasing levels of benefits and risks. Participants were excluded from analyses if their 
decisions fail to support a logistic regression model for any of the five social distances. 
Previous research has shown that variability in the social distance effects of these vaccine 
decisions is greatly reduced when considering moderate-to-severe side effects (Jarmolowicz 
et al., 2018), so results focused on influences of risk and benefit when considering mild side 
effects specifically.  
In order to allow for comparisons between the influences of risk and benefit, beta 
weights were standardized using the Long (1997) method as cited in Menard (2011). This 
method transformed the unstandardized beta weight values into units of standard deviation, 
based on their predictor values, as well as a constant which approximates the logistic 
regression curve. These beta weight values were assumed to violate assumptions associated 
with a normal distribution, and were investigated using non-parametric tests. First, one-
sample Wilcoxon signed rank tests were used to assess whether the impact of the beta weight 
values differ from zero. Wilcoxon Signed Rank tests were then used to examine whole 
sample differences in the influence of risk and benefit for each social distance.  
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Results next focused on differences in the influence of risk and benefit between 
hesitant and confident participants. Using Mann-Whitney U tests, hesitant and confident 
individuals were compared to examine whether group differences exist in the influence of 
risk and benefit at each level of social distance. Results then separated effects of risk and 
benefit, and compared the changes in influence with increasing social distance. Using 
Wilcoxon Signed Rank tests, the beta weight values for benefit were compared between 
Child and Person 5 decisions, Person 5 and Person 20, Person 20 and 50, and finally Person 
50 and 100. This pattern of analysis was repeated for risk beta weights. Finally, results were 
again split between hesitant and confident participants, so that differences in the relationship 
between social distance and risk/benefit beta weight values can be examined, again using 
Mann-Whitney U tests.  
As these results were exploratory in nature, significance was initially set at p < .05. 
Benjamini-Hochberg FDR correction was then used to adjust p-values accordingly. 
Statistical analyses were conducted using IBM SPSS Version 24.0, Microsoft Excel, and R. 
For our outcomes, a priori power analyses suggest that we would be sufficiently powered 
(80%) to detect medium interaction effect sizes with 30 or more participants for both 
confident and hesitant groups.  
		 39 
Figure 1. Example of paradigm assessing social distance effects. These questions are specific 
to vaccine decisions involving “Person 50” in the participant’s social network  
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Results 
Demographics 
    Table 1.  
    Summary of Demographics  
 
 
Table 1 outlines the relevant demographics of the included sample for the second set 
of analyses. In this sample, we initially collected 70 participants with VCS scores yielding a 
 
Demographics (n = 98) 
  
Age M = 37.1 SD = 10.1 
Gender 44 Female 54 Male 
Parental Status 42 Parents 56 Non-Parents 
Income Mdn = $58,966  
Vaccine Confidence Scale Hesitant = 42  Confident = 56 
   
Race   
Asian n=12  
African-American n=8  
Hispanic n=9  
Native American/Alaskan n=3  
White n=66  
   
Education   
Some high school n=1  
High School/GED n=12  
Some College n=26  
Associates/Vocational School n=11  
Bachelor’s Degree n=36  
Master’s Degree n=11  
Doctorate or Professional n=1  
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status of vaccine confident, and 50 participants deemed vaccine hesitant based on established 
criteria (Gilkey et al., 2014). Of the hesitant participants, five were excluded for reverse 
responses (indicating less willingness to vaccinate with increasing vaccine efficacy,). 
Similarly 12 vaccine confident participants were excluded for reverse responding. 
Participants also had to support a logistic regression model based on a predictor of risk of 
side effects (risk) and a predictor of vaccine efficacy (benefits) in order to be included. As a 
result, an additional five participants were excluded from these analyses due to lack of 
variation in responses, or failure to support a significant logistic model for either risk or 
benefit as a predictor (three hesitant and two confident). There were no observed differences 
in hesitant and confident participants for any of the demographic measures reported here (all 
p > .05). 
Behavioral Outcomes 
Figure 2 outlines the mean ranks for both risk and benefit beta weight values at each 
social distance, for hesitant and confident participants. One-Sample Wilcoxon Signed Rank 
tests were first run to establish that beta weight values for risk and benefit at each social 
distance were effective predictors of vaccination decisions (all predictors yielded p < .001). 
Next, between group analyses were carried out to determine differential effects of risk and 
benefit at each social distance. All analyses were carried out using standardized beta weight 
values, and for ease of interpretation, beta weight values were transformed to be positive 
numbers, with higher numbers indicating a greater influence on the decision to vaccinate. 
Table 2 illustrates these group analyses. The influence of risk was significantly different 
between hesitant and confident individuals for decisions considering benefits to Child and 
Person 100. In these decisions, the influence of risk was greater for hesitant participants 
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relative to confident participants. Confident participants showed increased influence for 
benefits at Person 5 and Person 50. P values for all behavioral outcomes were analyzed using 
Benjamini-Hochberg FDR correction, set at .05.  
 
Table 2. 
 
Comparison of beta weight values for risk and benefit at all social distances 
 
 Hesitant Confident     
Risk Mean Rank Mean Rank U Z p ηp2 
Child 56.4 44.32 886 -2.08 .037 0.04 
Person 5 51.6 47.93 1088 -0.63 .528 0.00 
Person 20 53.17 46.75 1022 -1.11 .269 0.01 
Person 50 51.18 48.24 1105.5 -0.51 .613 0.00 
Person 100 57.61 43.42 835.5 -2.45 .014 0.06 
 
Benefit 
     
 
Child  43.21 54.21 912 -1.90 .058 0.04 
Person 5 41.33 55.63 833 -2.46 .014 0.06 
Person 20  46.31 51.89 1042 -0.96 .340 0.01 
Person 50  40.75 56.06 808.5 -2.64 .008 0.07 
Person 100 42.99 54.38 902.5 -1.97 .049 0.04 
 
Note. Benjamini-Hochberg FDR correction used to adjust p-values for these 
analyses. Italics indicates p-value did not meet adjusted threshold for significance 
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Figure 2. Influence of Risk and Benefit on vaccine decisions. This figure depicts the mean 
rank of the beta weight values for risk and benefit to predict vaccine decisions. The mean 
ranks are split between confident and hesitant participants.  
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 Next, analyses focused on within groups differences in the influence risk and benefit 
had on vaccine decisions at various social distances. Wilcoxon Signed Rank tests were 
performed to differentiate the degree to which risk relative to benefit influenced decisions 
within hesitant and confident participants at each of the five social distances. Table 3 outlines 
these differences. These results suggest that risk influences vaccine decisions to a greater 
degree for vaccine hesitant participants at all social distances. However, risk and benefit 
equally influence decisions for vaccine confident participants, when only considering 
benefits to their child. At the increased social distances, vaccine confident participants are 
also more influenced by risk compared to benefit.  
 
 
Note. Benjamini-Hochberg FDR correction used to adjust p-values for these analyses. 
Negative mean ranks indicate that participants were more influenced by risk than benefit 
 
 
Table 3. 
Influence of risk and benefit within hesitant and confident participants 
 
 Benefit - Risk    
Hesitant 
Positive Mean 
Rank 
Negative Mean 
Rank Z p ηp2 
Child 13.1 24.13 -4.007 < .001 0.37 
Person 5 9.71 23.86 -4.795 < .001 0.53 
Person 20 8 24.2 -4.945 < .001 0.57 
Person 50 7 21.72 -5.398 < .001 0.68 
Person 100 8.67 22.49 -5.325 < .001 0.66 
Confident      
Child  25.21 32.04 -0.547 .585 0.01 
Person 5 17.75 33.86 -3.477 .001 0.21 
Person 20  19.27 30.76 -4.78 < .001 0.40 
Person 50  15 30.54 -5.32 < .001 0.50 
Person 100 12.46 32.81 -5.095 < .001 0.46 
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 Finally, analyses focused on the changes in the influence of risk and benefit with 
social distances. These analyses were split between hesitant and confident participants to 
examine how influences of the two predictors change differentially between groups. 
Analyses again used Wilcoxon Signed Rank tests to examine differences between risk beta 
weight values across social distance, and benefit beta weight values across social distance. 
Table 4 outlines these differences.  For hesitant individuals, the influence of risk was not 
significantly different for Child or Person 5 decisions. However, risk increased when moving 
from Person 5 to Person 20. Risk also increased in influence between Person 50 and Person 
100. Confident participants had greater influence of risk moving from Person 5 decisions to 
Person 20 decisions, but did not show differences between the remaining distances. 
Considering the influence of benefit on decisions, hesitant individuals showed a decrease in 
the influence between benefits to person 20 and person 50, and again from Person 50 to 
Person 100. Figure 3 depicts the separate influences of risk and benefit on vaccine decisions 
independently for vaccine confident and vaccine hesitant participants.  
 Because no differences were found in the influence of benefit as social distance 
increased for vaccine confident individuals, all pairwise comparisons were performed as a 
follow-up analysis to determine if any level of social distance differed from the others. The 
influence of benefits did not differ between any social distances, aside from Person 5 and 
Person 100 (Z = -2.51, p < .05). However, this comparison did not meet the criteria for 
significance after the Benjamini-Hochberg FDR correction. Results then suggest that vaccine 
confident participants showed no differences in the influence of benefit across all five social 
distances. 
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Note. Benjamini-Hochberg FDR correction used to adjust p-values for these analyses. Italics 
indicates p-value did not meet adjusted threshold for significance 
Negative mean ranks indicate that beta weight values for the closer social distance was 
ranked higher (i.e. Child > Person 5). 
 
Table 4.  
 
Social distance changes in risk and benefit beta weight values 
Hesitant  
Risk 
Positive Mean 
Rank 
Negative Mean 
Rank Z p ηp2 
Child – Person 5 21.06 21.77 -1.43 .152 0.05 
Person 5 – Person 20 12.7 20.12 -3.08 .002 0.22 
Person 20 – Person 50 13.67 21.25 -1.80 .072 0.08 
Person 50 – Person 100 9.63 19.92 -3.77 < .001 0.33 
      
Benefit      
Child – Person 5 23.67 19.88 -0.32 .750 0.00 
Person 5 – Person 20 15.31 20.26 -1.15 .252 0.03 
Person 20 – Person 50 18.54 15.86 -3.34 .001 0.26 
Person 50 – Person 100 17.67 17.1 -2.16 .031 0.11 
      
Confident       
Risk 
Positive Mean 
Rank 
Negative Mean 
Rank Z p ηp2 
Child – Person 5 19.89 31.95 -3.45 .001 0.21 
Person 5 – Person 20 26.61 27.94 -2.27 .023 0.09 
Person 20 – Person 50 23.43 28.58 -1.79 .073 0.06 
Person 50 – Person 100 25.35 24.76 -1.05 .294 0.02 
      
Benefit      
Child – Person 5 26.73 29.14 -0.63 .530 0.01 
Person 5 – Person 20 31.89 22.77 -1.30 .195 0.03 
Person 20 – Person 50 26.56 26.44 -0.26 .799 0.00 
Person 50 – Person 100 23.74 27.17 -1.23 .219 0.03 
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Figure 3. Log-transformed median beta weight values for risk and benefit at each social 
distance. These charts illustrate the differential influence that risk and benefit had on vaccine 
decisions. The first chart depicts hesitant participants, and the second confident participants. 
Values were log transformed to reduce scaling for illustrative purposes.  
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Discussion 
 Few studies have directly quantified the particular influences on vaccination 
decisions, and even fewer have analyzed how these influences may differ between vaccine 
hesitant and vaccine confident individuals. Specifically, our results focused on differences in 
the influence risk and benefit have between vaccine hesitant and vaccine confident 
individuals. Additionally, results describe the changes in amount of influence risk and benefit 
have when considering disease prevention in socially distant individuals. Our results show 
that hesitant and confident participants differ in how they weigh risks, benefits, and in social 
motivation during vaccine decisions considering mild side effects. Benefits had less of an 
impact in some socially proximate and socially distant decisions for hesitant participants. The 
influence of risk was significantly different between vaccine confident and vaccine hesitant 
individuals for Child-only and highly socially distant decisions. 
 Differences in the influence of risk and benefit were also seen within each group as 
social distance increased. Hesitant participants were more influenced by risk of side effects at 
each social distance, but vaccine confident individuals were equally influenced by both risk 
and benefit for decisions only concerning their child. Once decisions involved consideration 
of disease prevention in socially distant individuals, risk was more of an influence compared 
to benefit for vaccine confident individuals as well. This suggests that even for individuals 
who are confident in vaccines, the consideration of herd immunity may magnify the 
influence risk of side effects has on vaccine decisions. Research supports this conclusion, 
showing that risk of side effects garners a much higher influence on vaccine decisions, 
particularly if those are drawn from a narrative about adverse side effects (Betsch, Ulshofer, 
Renkewitz, & Betsch, 2011; Reyna, 2012). For vaccine hesitant individuals, the influence of 
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risk outweighs the influence of benefits at each social distance. In context with group 
differences, this suggests that while hesitancy decreases the value in perceived benefits of a 
vaccine, individuals who are confident in the efficacy of a vaccine may undergo a 
magnification of the perceived risk involved in a vaccination decision if the benefits of the 
vaccine are framed to involve herd immunity concepts as well. Importantly, our results also 
suggest that this increase in the influence of risk is specific to decisions involving benefit to 
highly socially distant individuals – for vaccine confident participants, this means beginning 
with Person 20.  
This concept is further illustrated by results which investigated the change in 
influence of risk and benefit separately with increasing social distance. For hesitant 
participants, the influence of risk on vaccine decisions was not significantly different 
between child-only decisions, and decisions involving benefit to Person 5. The influence of 
risk increased when considering benefits to Person 20, and again between Person 50 and 100. 
This suggests that the influence of risk magnifies between decisions involving socially 
proximate and socially distant individuals. Confident participants show a similar increase, 
but only between Person 5 and Person 20 decisions. The relationship between social distance 
and vaccine benefits is slightly different, as confident individuals seem to value the benefits 
of a vaccine equally across social distances. Hesitant individuals however again showed a 
significant difference between socially proximate and socially distant people, with a greater 
influence of benefits seen for Person 20 than Person 50 or Person 100.    
This suggests that while vaccine hesitant individuals devalue the benefits of a vaccine 
overall, benefits still retain an influence on vaccine decisions so long as the person benefiting 
is socially proximate. Appeals to this level of socially proximate benefits to vaccine hesitant 
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individuals may then prove to be a fruitful area of intervention in order to increase vaccine 
uptake. Previous research has established the direct benefits of vaccinating to protect socially 
proximate individuals (Reichert et al., 2001). Prosocial vaccination messages pointing to 
socially distant individuals may reduce perceived social distance, as previous research shows 
that this type of messaging can increase vaccination motivation (Li et al., 2016). Previous 
research has also shown that prosocial motivation and altruism does influence vaccine uptake 
in certain circumstances (Shim, Chapman, et al., 2012). Although our research supports the 
idea that the value placed on these benefits might decrease with social distance, results also 
show that benefits were still an impactful influence on decisions involving disease prevention 
in socially distant individuals.  
Hesitant individuals were shown to be highly influenced by the perception of risk, 
especially when considering preventing disease in socially distant individuals. Our results 
suggest appeals to socially proximate benefits to increase vaccine motivation in hesitant 
individuals might be the best option. Any campaign highlighting benefits to highly socially 
distant individuals may have the effect of increasing the influence risk has on their decision 
to vaccinate. Importantly, CDC and WHO campaigns that mention herd immunity principles 
currently only focus on extreme socially distant benefits, emphasizing that you add to the 
community as a whole by choosing to vaccinate. As evidence shows, there are much more 
proximal herd immunity benefits, such as preventing disease in your grandparents (Reichert 
et al., 2001). Our results show that these messages which only relate vaccination benefits to 
highly socially distant individuals may not have a positive impact on vaccine uptake, 
particularly for vaccine hesitant individuals. Messages that highlight benefits to close family 
members may reduce the potential increase risk perception involved with prosocial vaccine 
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messaging. As hesitancy is not just related to outright vaccine refusal, but also to delayed or 
partial refusal, a method of intervention appealing to socially proximate benefits, while also 
downplaying the risks involved in vaccinations would be specifically suited to increase 
uptake in hesitant individuals. Risks in particular have been shown to have an increased 
effect on decision-making for vaccination decisions, and thus any method designed to reduce 
the perceived risk of side effects while maintaining accuracy for informed decision making 
should be of high importance (Reyna, 2012).  
Limitations and Future Directions 
 This study is an initial investigation aiming to elucidate differences in the direct 
underlying influences on vaccine decisions between vaccine confident and vaccine hesitant 
individuals. Primarily, these investigations are limited in their application, as all questions 
were hypothetical in nature. Questions did not specify one vaccine over another, and many 
parents have concerns over specific vaccines, such as MMR and autism, or concern over the 
true efficacy of the flu vaccine. Future research should aim to delineate any differences in the 
use of specific vaccines.  Second, 21 participants were removed for data quality purposes. 
Online administration may explain some of this poorer data quality, however previous 
research using social distance paradigms saw similar numbers of excluded participants (Jones 
& Rachlin, 2006; Jones & Rachlin, 2009; Rachlin & Jones, 2008b). Our study focused on the 
two theoretically primary drivers of vaccine decisions as predictors – risk of side effects, and 
vaccine efficacy. Other predictors likely exist, and should be incorporated into future 
investigations. The history of vaccine hesitancy contains motivations like personal liberty 
and religious exemptions as well, which could further explain some of the differences in 
motivation to vaccinate.  
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 Overall, our study has provided sufficient evidence to suggest that vaccine hesitant 
and vaccine confident individuals differ in the way risk and benefit influence their decisions. 
Further, the relationship between hesitancy and social motivation to vaccinate is highly 
complex, with confident individuals weighing benefits equally as social distance increases, 
and hesitant individuals weighing the benefits more highly for socially proximate persons 
relative to socially distant ones. Even those confident in vaccine efficacy display an increased 
influence of risk as the benefits are discussed in a prosocial light. Messages then designed to 
increase contributions to herd immunity should be carefully crafted to ensure that they avoid 
actually reducing vaccine intentions. By using messages directed at socially proximate 
benefits, as well as personal benefits, one might optimally increase vaccine uptake. These 
insights should be used to inform settings like pediatric clinics, where consultations with 
current and future parents are geared toward the discussion of the risks and benefits involved 
in vaccination decisions. 
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CHAPTER 3 
ADDITIONAL ANALYSES 
 To further investigate group differences in overall willingness to risk side effects, 
additional analyses were carried out for the first paper, entitled Vaccine Hesitancy and Social 
Motivation During Vaccine Decisions. These analyses focused on potential differences in 
willingness to risk side effects, particularly examining questions from our paradigm where 
vaccine efficacy was medium, or high, relative to the overall willingness used in the paper. 
Separate ANOVA’s support main effects for social distance [F(2.6, 228.8), = 31.2, p < .001, 
ηp2 = .27] and hesitancy [F(1, 88), = 18.8, p < .001, ηp2 = .18] for Medium efficacy decisions 
and mild side effects. High efficacy decisions and mild side effects also had significant 
effects of social distance [F(2.4, 213.5), = 41.6, p < .001, ηp2 = .32] and hesitancy [F(1, 88), 
= 7.8, p < .01, ηp2 = .08].  For moderate-to-severe side effect decisions, Medium efficacy still 
carried a significant effect of social distance [F(2, 173), = 5.5, p < .01, ηp2 = .06], but 
hesitancy was not significant [F(1, 88), = 1.3,  p < .26, ηp2 = .01].  
High efficacy decisions considering moderate-to-severe side effects showed a similar 
relationship, with a significant effect of social distance [F(2.1, 181), = 16.5, p < .001, ηp2 = 
.16], but not hesitancy  [F(1, 88), = 1.2,  p < .28, ηp2 = .01]. Tables 1 and 2 illustrate follow 
up t-tests comparing hesitant and confident participants in these two conditions. Overall, the 
results are very similar to the results seen using the average overall willingness to risk side 
effects. In fact, looking at group differences in moderate decisions specifically, the pattern of 
differences is nearly identical with each way of examining the data. Hesitant and confident 
groups differ at all levels of social distance when considering mild side effects, but when 
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considering moderate-to-severe side effects, participants did not show any significant 
differences. 
Finally, the Multidimensional Scale of Perceived Social Support was proposed as a 
potential correlate of vaccine decisions involving socially distant individuals. After further 
consideration this measure was not considered for analyses in order to reduce the potential 
for familywise error.  
		
 
 
  
 
 
 
 
 
 
 
 
 
 
       Note: Comparisons used willingness to risk side effects for a vaccine that had a 50% chance to prevent disease  
 
 
 
Table 1. 
 
Group differences in willingness to vaccinate at each social distance for medium efficacy vaccines 
 
 Hesitant Confident     
Mild Decisions M SD M SD t df p d 
Child 0.165 0.229 0.548 0.342 -6.32 84.2 <.001 -1.38 
Person 5 0.138 0.208 0.384 0.354 -4.09 79.5 <.001 -0.92 
Person 20 0.130 0.215 0.270 0.316 -2.48 84.8 .015 -0.54 
Person 50 0.067 0.141 0.216 0.292 -3.16 71.7 .002 -0.75 
Person 100 0.060 0.152 0.185 0.279 -2.70 76.5 .009 -0.62 
Moderate-to-Severe Decisions         
Child 0.060 0.140 0.124 0.192 -1.82 86.5 .072 -0.39 
Person 5 0.051 0.139 0.114 0.212 -1.67 83.7 .099 -0.36 
Person 20 0.054 0.150 0.090 0.193 -0.96 88.0 .339 -0.20 
Person 50 0.051 0.150 0.067 0.158 -0.49 88.0 .624 -0.10 
Person 100 0.049 0.150 0.057 0.143 -0.26 88.0 .794 -0.06 
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       Note: Comparisons used willingness to risk side effects for a vaccine that had a 99% chance to prevent disease
Table 2. 
 
Group differences in willingness to vaccinate at each social distance for high efficacy vaccines 
 
 Hesitant Confident     
Mild Decisions M SD M SD t df p d 
Child 0.479 0.413 0.858 0.276 -5.02 67.6 <.001 -1.22 
Person 5 0.443 0.411 0.638 0.425 -2.21 88.0 .030 -0.47 
Person 20 0.377 0.420 0.490 0.441 -1.24 88.0 .220 -0.26 
Person 50 0.262 0.364 0.430 0.441 -1.99 88.0 .050 -0.42 
Person 100 0.198 0.351 0.367 0.437 -2.03 87.9 .045 -0.43 
Moderate-to-Severe Decisions         
Child 0.180 0.341 0.342 0.376 -2.12 88.0 .036 -0.45 
Person 5 0.138 0.318 0.240 0.369 -1.38 88.0 .170 -0.29 
Person 20 0.158 0.343 0.208 0.359 -0.67 88.0 .506 -0.14 
Person 50 0.130 0.319 0.169 0.335 -0.57 88.0 .573 -0.12 
Person 100 0.126 0.318 0.154 0.326 -0.40 88.0 .689 -0.09 
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CHAPTER 4 
ORIGINAL PROPOSAL 
Summary 
Vaccines have been used to prevent disease for over 200 years. From their inception, 
vaccines have met resistance from groups arguing against their efficacy and safety.  Despite 
some worldwide progress with diseases like measles (Patel et al., 2016) global average 
vaccination rates have actually dropped as much as 6% (Ehreth, 2003). Many of these events 
can be tied to parents who are termed “vaccine hesitant,” a spectrum of low confidence in 
vaccines that can result in delay or refusal of childhood vaccination (Larson, Jarrett, 
Eckersberger, Smith, & Paterson, 2014). One reason why vaccine hesitancy can be 
detrimental to community health is related to the concept of herd immunity. With herd 
immunity, high vaccine coverage can provide indirect protection to vulnerable members of 
the population, without the need for them to be vaccinated (Fine, Eames, & Heymann, 2011). 
Yet, as seen with personal belief exemptions and vaccine refusal, it is sometimes difficult to 
attain high enough coverage to provide herd immunity (Gaudino & Robison, 2012).  
 Certain vaccine decisions, in order to protect other people, would involve altruistic 
motivations (Bauch & Galvani, 2013). The current studies aimed to elucidate what drives 
motivation to vaccinate, and how those motivations differ when individuals are confident or 
hesitant about vaccination procedures and policy. Study One of this dissertation carried the 
following specific aims: (1) Determine differences in overall willingness to vaccinate 
between hesitant and confident individuals; (2) Examine the relationship between social 
distance, hesitancy, and willingness to vaccinate; (3) Examine correlations between self-
report measures and willingness to vaccinate at different social distances. Study Two had the 
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following aims: (1) Delineate the influences of risk and benefit on vaccine decisions; (2) 
Compare the influence of risk and benefit on vaccine decisions between hesitant and 
confident participants; (3) Investigate changes in the influence of risk and benefit with social 
distance. 
Methods 
Participants 
Participants will be recruited via Amazon Mechanical Turk (mTurk) online services 
(www.mturk.com), similar to a previous study using our paradigm (Jarmolowicz et al., 
2018). Amazon mTurk provides a platform for requesters to directly recruit human 
participants for various purposes. Workers sign up to voluntarily complete “human 
intelligence tasks”, or HIT’s, for varying levels of compensation. Participants through the 
mTurk service will be routed to a SurveyMonkey page (www.surveymonkey.com ) that 
contains the vaccine paradigm and self-report measure described in subsequent sections. All 
study procedures have been approved by the UMKC IRB. Participants will be excluded if 
they fail to complete all sections of our paradigm and self-report measures.  
Paradigm 
Participants will be presented with a series of questions asking them to indicate the 
highest likelihood of side effects they would be willing to subject their child to, given varied 
likelihoods of disease prevention. If participants do not have a child, they will be asked to 
imagine making this decision for their future child.  To increase the generalizability of the 
paradigm and avoid social stigmas that can be associated with certain vaccines (e.g. HPV and 
sexual activity) a specific disease is not indicated. Before beginning the paradigm, 
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participants will be shown a brief description and definition of what vaccines are, which 
reads as follows: 
“A vaccine is defined here as a product that stimulates a person’s immune 
system to produce immunity to a specific disease, protecting the person from 
that disease. Vaccines are usually administered through needle injections, but 
can also be administered by mouth or sprayed into the nose. 
Vaccines are used to prevent specific diseases from occurring. Vaccines have 
been demonstrated to prevent diseases like Measles, Mumps, and Rubella, as 
well as cervical cancer caused by HPV, and even the seasonal flu. Vaccinating 
your child can prevent them from contracting one of these diseases. 
Vaccinating your child can also benefit the community. Vaccinating your 
child against various infections can prevent them from contracting disease, 
which also stops the disease from spreading to others.  
Some individuals are unable to receive vaccines themselves, which leaves 
them susceptible to infections that can be prevented in other individuals by 
using vaccinations.” 
Three example questions are included in the instruction set, which present a hypothetical 
participant who indicates her willingness to risk side effects for three levels of disease 
prevention. Participants are asked to mark the response that corresponds with the 
hypothetical participant’s choices.  
Questions for the paradigm will present participants with a given vaccine efficacy, 
and ask them to indicate the highest risk of side effects they are willing to subject their child 
to for the given probability of disease prevention. Each question will have the same array of 
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15 potential responses that correspond with increasing risk likelihood, ranging from 0 to 
99%. For ease of interpretation, and to be consistent with CDC presentation of side effect 
likelihoods, options were presented as “1 out of 1000.” Figure 1 illustrates the format that 
questions and options will be presented to each participant for mild side effects. These same 
12 questions were then repeated for a second level of side effect severity (indicated as 
moderate-to-severe). The particular side effects that constituted the two side effect severities 
were collected from the CDC website (CDC, 2015). Example possible mild side effects 
included headache, nausea, and bruising. Example possible moderate/severe side effects 
included pneumonia, severe pain and bleeding, and coma. 
Social Distance 
Adapting a procedure from Jones and Rachlin (2006), the paradigm will incorporate a 
method to establish how motivation to vaccinate changes when considering individuals 
socially distant to the participant. To assess these factors, the paradigm asks participants to 
imagine all of their friends, relatives, and acquaintances into a quantifiable social network, in 
which they rank these individuals on a scale from 1-100. In this method, a rank of 1 is given 
to their closest, most socially proximal person (spouse, parent, best friend, etc.), and “person 
100” represents an absolute stranger. Multiple individuals can inhabit the same ranking, but 
participants will be asked to specify particular individuals (and their specific relation to the 
participant) for ranks of 3, 5, 10, and 20. The exercise of naming all of these individuals aims 
to help the participant understand the concept of social distance – our study will focus on 
individuals at distances of 1 (child), 5, 20, 50, and 100.  
When making the vaccine decisions, participants are told that by vaccinating their child, they 
have the opportunity to prevent others from contracting disease as well. In order to assess 
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motivation, or willingness, to prevent others from contracting a disease by vaccinating their 
children, questions are designed by asking how willing they are to risk side effects from a 
vaccine in their child, in order to protect an individual in their social network from 
contracting a disease. For questions assessing willingness to prevent disease in persons 5 and 
20, the particular name each participant used when outlining their social network will be 
imported into the questionnaire. For persons 50 and 100, because these are assumed to be 
unnamed acquaintances, “Person 50” and “Person 100” will be used in place of names. 
Additionally, following the format from Strombach et al., (2015), a diagram will be 
employed to visualize all 100 individuals in their social network (see Figure 1).  
In the full paradigm, participants will first be asked how willing they are to risk side 
effects to their child, in order to prevent disease in their child. Following that, they will be 
asked to indicate how willing they are to risk vaccine side effects in their child, in order to 
prevent disease in particular members of their social network. The same 12 levels of vaccine 
efficacy and 15 options of risk will be repeated across each level of social distance 
considering risk of mild side effects, and then all options will be repeated again for decisions 
involving “moderate-to-severe” side effects, for a total of 120 questions (five social 
distances, 12 questions, two levels of side effect severity). Participants were paid $10 upon 
full completion of the study.  
Because each question has the same 15 response options of side effect probabilities 
and participants were asked to indicate their highest value of acceptable side effect risk, any 
value lower than their indicated value will also be considered as a “yes”. For example, if a 
participant indicates that they would accept a 25% risk of side effects they would also 
logically accept risks of 10% and 15%, as these are lower values. Following this idea, it is 
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possible to code each pair of side effect risk and vaccine efficacy resulting in 15 binary 
(yes/no) responses per question. This makes a total of 180 responses within each social 
distance, for a total of 900 binary responses per participant including all five of the 
socialdistances which will be used in logistic regressions. Participant responses will be 
examined for logical accuracy (more willing to risk mild side effects compared to 
moderate/severe). In addition, three example questions will be included to assure task 
comprehension.  
Self-Report Measures 
Vaccination Confidence Scale (Gilkey et al., 2014). The Vaccination Confidence 
Scale (VCS) will be used to split participants into those low or high in vaccine confidence. 
This scale assesses attitudes about vaccination along several metrics, with the overall levels 
of confidence. Previous research establishing the VCS showed that approximately 5% of the 
population would indicate sufficient levels of vaccine hesitancy on the VCS to score <=6 
(Gilkey et al., 2014). Participants will then be split along the suggested guidelines of <=6 
suggesting low vaccine confidence, and >=6 supporting medium or high vaccine confidence. 
Comparisons will be made between these two groups. Previous research with the VCS has 
suggested that these groups differ fundamentally in their decision making, and should be 
treated as independent subjects (Gilkey et al., 2014). 
Social Network Index (Cohen, Doyle, Skoner, Rabin, and Gwaltney, 1997). The 
social network index (SNI) provides a comprehensive picture of the size and makeup for an 
individual’s social network. It will be used to investigate correlations with vaccine decisions 
regarding socially distant individuals.   
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Figure 1. Example of paradigm assessing social distance effects. These questions are specific 
to vaccine decisions involving “Person 50” in the participant’s social network.  
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Prosocial Personality Battery (Penner, Fritzsche, Craiger, and Freifeld, 1995). The 
prosocial personality battery (PSB) will be used to assess the prosocial tendencies of the 
participants. It includes subscales that describe a participant’s perspective  
 taking, empathic concern, ability to deal with personal distress, moral reasoning, and self-
reported altruism. 
Multidimensional Scale of Perceived Social Support (Zimet, Dahlem, Zimet & 
Farley, 1988). The Multidimensional Scale of Perceived Social Support (MDSPSS) will be 
used to describe the social support that each participant has regarding their close friends, 
family, and relationships. It includes three subscales to assess the support drawn from family 
members, friend groups, and a significant other. Participants will also be compared for 
differences in observed metrics between gender, ethnicity, age, income, parental status, and 
education. Any observed differences will be controlled for during analyses. Participants with 
higher degrees of social support may be more likely or able to deal with potential 
consequences of vaccine side effects, increasing their willingness to risk side effects to 
prevent disease.  
Analytic Methods 
Paper One.  Our analysis methods will be based around the aims of the two studies 
first, we aim to determine differences in overall willingness to vaccinate between hesitant 
and confident individuals. Average willingness to vaccinate will be calculated for each 
social distance. This measure will be calculated by averaging the willingness to risk side 
effects for each level of vaccine efficacy within a social distance. These measures will then 
be used to compare changes in willingness to vaccinate as social distance increases. The 
same measure will be calculated for decisions involving mild side effects and moderate-to-
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severe side effects.  An overall 5 (Social Distance) x 2 (Hesitancy Status) x 2 (Side Effect 
Severity) ANOVA will first be run to investigate if an interaction exists across the full model 
of vaccine decisions.  
Second, we aim to examine the relationship between social distance, hesitancy, 
and willingness to vaccinate. Follow up analyses will investigate effects within the two side 
effect severities. Separate 5 (Social Distance) x 2 (Hesitancy) ANOVAs will be run for the 
two side effect severities, and further analyses will examine how willingness to vaccinate 
differs between social distances and vaccine hesitancy.  
Finally, we aim to examine correlations between self-report measures and 
willingness to vaccinate at different social distances. Correlations will be run using 
willingness to vaccinate and self-report measures described earlier. Correlations will first be 
run on the whole sample, then, pending differences in decision-making between groups, 
separate correlations will be run for hesitant and confident individuals. Both Pearson’s and 
Spearman’s rank order correlations will be run to assess potential violations of normality in 
the vaccine decision-making data. We hypothesize that measures of social network size will 
positively correlate with willingness to vaccinate socially distant individuals. Presumably, 
individuals with larger social networks may have a larger pool of potential individuals that 
they run the chance of spreading disease to. This increase in social network size may factor 
in to their decisions to protect those in their social networks from contracting a disease that 
they (or their children) might spread. Further, measures of prosocial behavior will correlate 
with willingness to vaccinate socially distant individuals as well. These correlations will all 
be considered exploratory analyses.  
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Paper Two. First, we aim to delineate the influences of risk and benefit on vaccine 
decisions. To investigate the separate influences that changing levels of side effect risk (risk) 
and vaccine efficacy (benefit) will have on vaccine decisions, logistic regressions will be 
used on an individual level for each participant. Risk and benefit will be entered into the 
model together, with decision to vaccinate for each paring of side effect risk and vaccine 
efficacy coded as a binary outcome (yes/no). Results then will yield individual beta weights 
for the influence of increasing levels of benefits and risks. Participants will be excluded from 
analyses if their decisions fail to support a logistic regression model for any of the five social 
distances. Previous research has shown that variability in the social distance effects of these 
vaccine decisions is greatly reduced when considering moderate-to-severe side effects 
(Jarmolowicz et al., 2018), so results will focus on influences of risk and benefit when 
considering mild side effects specifically.  
In order to allow for comparisons between the influences of risk and benefit, beta 
weights will be partially standardized. The partially standardized beta values will be 
calculated using Long (1997) method of standardization found in (Menard, 2011). This 
method transforms the unstandardized beta values into units of standard deviation based on 
their predictor values, as well as a constant which approximates the logistic regression curve. 
These beta values are assumed to violate assumptions associated with a normal distribution, 
and will be investigated using non-parametric tests. First, one-sample Wilcoxon signed rank 
tests will be used to assess whether the impact of the beta values differ from zero. Wilcoxon 
Signed Rank tests will also be used to examine whole sample differences in the influence of 
risk and benefit for each social distance.  
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Next, we aim to compare the influence of risk and benefit on vaccine decisions 
between hesitant and confident participants. Results will focus on differences in the 
influence of risk and benefit between hesitant and confident participants. Using Mann-
Whitney U tests, hesitant and confident individuals will be compared to examine if group 
differences exist in the influence of risk and benefit at each level of social distance. 
 Last, we aim to investigate changes in the influence of risk and benefit with social 
distance. Results will separate effects of risk and benefit, and compare the changes in 
influence with increasing social distance. Using Wilcoxon Signed Rank tests, the beta values 
for benefit will be compared between Child and Person 5 decisions, Person 5 and Person 20, 
Person 20 and 50, and finally Person 50 and 100. This pattern of analysis will be repeated for 
risk beta values. Finally, results will be split between hesitant and confident participants, so 
that differences in the relationship between social distance and risk/benefit beta values can be 
examined, again using Mann-Whitney U tests.  
As these results are exploratory in nature, significance will be set at p < .05. When 
necessary for multiple comparisons, FDR correction will be implemented (Benjamini & 
Hochberg, 1995). Statistical analyses will be conducted using IBM SPSS Version 24.0, 
Microsoft Excel, and R. For our primary outcomes, a priori power analyses suggest that we 
would be sufficiently powered (80%) to detect medium interaction effect sizes with 30 or 
more participants for both confident and hesitant groups.  
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CHAPTER 5 
LITERATURE REVIEW 
Introduction 
Vaccines have been used to prevent disease for over 200 years. But from their 
inception, vaccines have been met resistance from groups arguing against their efficacy and 
safety.  Despite some worldwide progress with diseases like measles (Patel et al., 2016) 
global average vaccination rates have dropped as much as 6% in recent years (Ehreth, 2003). 
Certain isolated incidents of vaccine refusal, like San Diego in 2008, have resulted in 
exposure of nearly 1,000 unvaccinated children to measles (Sugerman et al., 2010). Many of 
these events can be tied to parents who are termed “vaccine hesitant” a spectrum of low 
confidence in vaccines that can result in delay or refusal of childhood vaccination (Larson, 
Jarrett, Eckersberger, Smith, & Paterson, 2014). Investigating methods to influence parental 
vaccine hesitancy is a novel and promising area of research. Currently, little is known about 
how to best sway these vaccine hesitant parents to adopt a more accepting vaccine attitudes 
(Jarrett et al., 2015). 
One reason why vaccine hesitancy can be detrimental to community health is related 
to the concept of herd immunity. With herd immunity, high vaccine coverage can provide 
indirect protection to vulnerable members of the population, without the need for them to be 
vaccinated (Fine, Eames, & Heymann, 2011). Yet, as seen with personal belief exemptions 
and vaccine refusal, it is sometimes difficult to attain high enough coverage to provide herd 
immunity (Gaudino & Robison, 2012). Additionally, parents do not seem to fully understand 
the concept of herd immunity, or may not be aware of its benefit; research shows it is not 
commonly cited as a primary motivator when considering vaccine benefits (Sobo, 2016). 
		 72 
Certain vaccine decisions, in order to protect other people, would involve altruistic 
motivations (Bauch & Galvani, 2013). One tool to identify motivators for altruistic 
vaccination decisions has been game theory. Game theory is used to identify separate 
motivational influences on the decision to vaccinate, or not. Research suggests that the desire 
to provide indirect protection to others may be high or low depending on the circumstances 
for each individual and context (Vietri, Li, Galvani, & Chapman, 2012). This review serves 
as an overall guide to the history of vaccines, as well as how and why vaccinations and their 
policies are met with hesitancy from some groups. It also examines how differing 
motivations lead to vaccine acceptance versus refusal, and suggests that altruism is a 
necessary component in order to achieve the rates of vaccination needed for disease 
eradication and herd immunity. Last, the use of social distance to consider differing attitudes 
towards vaccine benefits is suggested as an area for future research. 
A Brief History of Vaccines 
The first record of using disease particles to provide immunity in healthy individuals 
was in response to smallpox. Some early accounts suggest that the Chinese were using 
methods of nasal insufflation of powdered smallpox as early as the Fifteenth century 
(Silverstein, 2009). Modern accounts of vaccines as a preventative measure for disease 
control date to the late Eighteenth century, with the advent of a method to inoculate smallpox 
in 1798 (Plotkin, 2014; Silverstein, 2009; Stern & Markel, 2005). Originally, the process of 
inducing immunity from smallpox was carried out by variolation, a process that used several 
methods of introducing a disease to healthy individuals (Plotkin, 2014). One common 
method required taking the scabs or pus of smallpox from an infected individual then 
crushing them into a powder. This powder was either rubbed onto the skin of a healthy 
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person, or injected, in order to induce future immunity. This process was amended by 
Edward Jenner, who took cowpox, a similar but much milder disease, and used it to provide 
individuals future immunity from smallpox (Stern & Markel, 2005). Jenner’s hypothesis for 
this method of immunity was derived from many sources, but primarily he noticed that the 
milkmaids in his village, who frequently came into contact with cows infected with cowpox, 
showed high immunity to the smallpox outbreaks that would frequent his village. This use of 
a modified version of the disease to confer immunity led to the modern-day idea of 
vaccination, a term that we now use to refer to the process of immunizing individuals from a 
large variety of diseases (Stern & Markel, 2005).  
As in modern vaccines, this method causes the body to activate the immune system, 
synthesizing specific antibodies that would be able to fend off the disease if presented again 
to the body. The difference is that these diseases were not attenuated in any way. Jenner’s 
cowpox to smallpox immunity hypothesis relied on the idea that between a cow and a human, 
the pox disease would be attenuated, or reduced in its severity (Plotkin, 2014). In essence, 
contracting cowpox was preferable to contracting the potentially lethal smallpox and would 
protect the individual from contracting smallpox in the future. All early methods of 
conferring immunity relied on the principle of live attenuation, a process that would take a 
live version of a disease and modify it somehow to make it less virulent (Plotkin, 2014). 
Jenner’s method assumed that a disease virulent in animals would be attenuated when 
transferred to humans. Louis Pasteur took the work by Jenner and expanded it by using 
exposure to heat and oxygen to attenuate rabies and anthrax vaccines for use in humans 
(Stern & Markel, 2005). This method is still considered live attenuation, as the pathogens 
used in the vaccine were still living versions of the disease. Pasteur also expanded the use of 
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the word vaccination, which originally was a term that specifically referred to Jenner’s 
method of providing immunity from smallpox via cowpox. Vaccine as a term has its roots in 
the Latin vaccus or vaccinus, meaning "from cows" (Stern & Markel, 2005). In honor of 
Jenner, Pasteur expanded the term to include all inoculation forms. The next stage in vaccine 
development modified the process of attenuation. Serial cultivation, or serial passage, 
involves attenuating a disease by iteratively exposing a virus to in vitro specimens (Plotkin, 
2014). In this process, part of the virus would be removed and introduced to a new specimen 
repeatedly, and each new presentation would reduce the virulence that the disease presented. 
Calmette and Guérin were the first individuals to implement this method of serial 
passage, using bovine tuberculosis bacteria (Plotkin, 2014). By exposing the bovine virus to 
an in vitro specimen 230 times they were able to obtain an attenuated strain that would safely 
inoculate against human forms of tuberculosis. This pioneering method eventually led to the 
modern vaccine attenuation method, called cell culture. In order to produce less infectious 
strains, viral cells are grown in vitro and allowed to replicate freely. As the cells replicate, the 
strains that have mutated traits lower the likelihood of spreading infection are selected and 
allowed to replicate again. This process is repeated until the mutated strains of the disease 
have generally lost, or at least modified, the ability to infect and spread within a human host 
(Plotkin, 2014).  
Once the mutated strain has lost the ability to infect human hosts, it has been 
sufficiently attenuated and can serve as a source of vaccination. The most recent 
developments into vaccine technology include methods of RNA reassortment, chemical 
inactivation, the use of capsular polysaccharides, protein-based vaccines, and genetic 
engineering, all as ways to attenuate virulency and provide immunity (Plotkin, 2014). 
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Hesitancy and Resistance to Use of Vaccines 
There is an inherent risk of contamination during development due to the nature of a 
vaccine. All vaccines are essentially biological agents, which can be easily compromised as 
they are being processed and manufactured. As a result, the standards for vaccine 
development are very stringent, requiring many levels of quality control, monitoring, and 
sterilization of the production environment. Aside from issues related to production, the 
method by which a vaccine produces immunity involves injecting attenuated versions of 
actual disease particles in many cases. Because of this, it is vital to ensure that the use of a 
vaccine does induce the very disease it is supposed to grant immunity from. For example, 
one outbreak of polio occurred in 1955 as a result of a vaccine containing active wild-type 
polio virus which unfortunately caused 200 cases of polio in children, killing five of them 
(Stern & Markel, 2005). 
The complication surrounding vaccine production and their inherent risk has always 
added to the fear surrounding vaccines and their safety. From their onset with Jenner’s 
method, there has been a resistance to the use of vaccines as a means of producing immunity. 
Beginning in the 1800’s, Jenner’s method of animal attenuation produced cartoon depicted 
comparisons of humans turning into cows as a result of taking cowpox derived vaccines 
(Stern & Markel, 2005). The debate surrounding the best methods of vaccine production 
even varies within the field of immunology. Using the polio vaccine as an example, there 
was debate over whether a live vaccine should be used over a killed version (Plotkin, 2014). 
Measles vaccines, Bacillus Calmette–Guérin (BCG) vaccines, and concerns around 
thimerosal-containing vaccines have 
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also sparked safety concerns inside and outside the field of immunology. The most well-cited 
case made against vaccines dealt with a proposed connection between autism and the 
currently used measles-mumps-rubella vaccine (MMR), which has been widely debunked by 
a consensus of scientists (Parker, Schwartz, Todd, & Pickering, 2004). Concerns about 
vaccine safety have also justified legislation. The National Childhood Vaccine Injury Act 
(NCVIA) was put forth due to parental concerns over a supposed link between vaccines and 
developmental neurological problems (Stern & Markel, 2005). The compulsory nature of 
some vaccine policies has generated resistance from the onset of vaccination use. Some 
individuals, past and present, resent the forced nature of vaccine mandates, citing 
infringement on personal liberties and government intrusion into the private realm. In certain 
cases, legislation was passed to vaccinate “for the greater good”, particularly smallpox in 
1905 (Stern & Markel, 2005). The Supreme Court ruling in Jacobson vs Massachusetts stated 
that compulsory vaccination was required as the need for protecting public health outweighed 
an individual’s right to privacy. This belief is not commonly held by the general public, 
although research supports the suggestion that the only way to achieve herd immunity will be 
through compulsory vaccination policy (Bauch, Galvani, & Earn, 2003). 
Taken together, concerns over vaccine safety and vaccine policy have produced a 
sub- culture of vaccine hesitancy. This differs slightly from outright vaccine refusal, as these 
individuals may believe that vaccines can have benefits but maintain some reservations 
related to the safety and regulation of vaccine and vaccination policy. The term “vaccine 
hesitancy” was defined by MacDonald et al., (2015) as “a delay in acceptance or refusal of 
vaccination despite availability of vaccination services. MacDonald et al. (2015) goes on to 
discuss vaccine hesitancy as “complex and context specific, varying across time, place, and 
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vaccines.” They further note that vaccine hesitancy can be influenced by complacency, 
convenience, and confidence. Understanding vaccine hesitancy may be important because 
some of these individuals, with the right types of information and presentation style, could be 
swayed to vaccinate when they would otherwise refuse (Dube, Gagnon, MacDonald, 2015). 
Many studies have investigated the correlates of under-vaccination and non-
vaccination. Beginning with a review that targeted low and middle income countries, factors 
ranged from organizational issues within the countries’ vaccination programs to poor 
communication and dissemination of information (Rainey et al., 2011). In these poorer 
countries, the most prevalent issues linked to non-vaccine status were inability to access 
vaccination services due to distance or general availability and family characteristics like low 
literacy levels or being part of a minority group were the second most prevalent. To a lesser 
extent, parental attitudes like lack of knowledge related to vaccination, fear of adverse 
events, lack of motivation, and mistrust of healthcare systems were predictors of non-vaccine 
status. Lower vaccine uptake was also associated with communication issues, such as 
inaccuracy of available information, language barriers between patients and healthcare 
workers, or lack of an integration of the vaccination program with the community (Rainey et 
al., 2011).  
Several studies have examined the degree to which factors associated with vaccine 
hesitancy might influence vaccine uptake. For example, research from Japan has shown that 
the sole motivator in refusing influenza vaccines was the fear of adverse reaction (O. 
Takahashi et al., 2003). Investigations into personal belief exemptions from mandatory 
vaccine policies show factors like distrust of local doctors, childbirth at an alternative 
hospital site, and reported knowledge of a vaccine-hurt child as predictive of refusing to 
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comply with a given policy (Gaudino & Robison, 2012). Aside from these cited reasons, the 
highest predictors were simply negative beliefs about vaccines and strong vaccine concerns 
(Gaudino & Robison, 2012). In certain cases the underlying issues related to hesitancy are 
more complicated, such as the vaccine against human papillomavirus (HPV). In the case of 
HPV, characteristics that increase likelihood of vaccine uptake include age, number of 
vaccine information resources, and higher vaccine-related knowledge. In contrast, vaccine 
uptake was not associated with an understanding of risk of HPV related diseases (Mathur, 
Mathur, & Reichling, 2010). Other studies suggest that parents think the HPV vaccine needs 
higher efficacy rates in order to increase uptake (Hofman et al., 2014). General health 
literacy has been shown to increase the uptake of vaccines, suggesting that an overall 
knowledge of health related issues may underlie some individual’s decisions to vaccinate 
(Veldwijk et al., 2015). Additionally, some parents express hesitancy related to the number 
or time-schedule of vaccine administrations, and space out or show partial refusal of the 
standard vaccine course (Hulsey & Bland, 2015). These concerns can be summed into an 
concept called “immune overload”, and despite readily available information regarding 
vaccine safety, some parents are still reluctant to follow the recommended course (Hulsey & 
Bland, 2015). 
Addressing Vaccine Hesitancy 
The breadth of factors related to vaccine hesitancy suggests that multifaceted 
approaches are necessary to increase vaccine uptake. Direct influences, unfortunately, have 
not been shown effective overall (Sadaf, Richards, Salmon, & Omer, 2013). In 2012, a task 
force known as the SAGE Working Group on Vaccine Hesitancy) was formed by the World 
Health Organization (WHO) in order to assess and address global concerns regarding vaccine 
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hesitancy. The WG’s main goal was to establish a definition of hesitancy, in addition to 
determining the behavioral factors that would drive and influence the ultimate decision to 
vaccinate or not. The research addressing vaccine hesitancy, both inside and outside the 
United States, is not entirely promising. Two recent review papers concluded that there is no 
convincing evidence for the efficacy of interventions designed to reduce vaccine hesitancy 
(Jarrett et al., 2015; Sadaf et al., 2013). 
There is some evidence that mass vaccination programs can have an influence on 
general positive attitudes about vaccines, which could eventually lead to increased uptake 
(Eskola, Duclos, Schuster, & MacDonald, 2015). However, the evidence from these studies 
stems largely from campaigns run through mass media, and are subject to many biases 
related to the method of intervention delivery (Dube et al., 2015; Larson et al., 2015). 
Evidence also suggests that campaigns that take an extreme hardline in advocating for 
vaccination can cause alienation among people hesitant about vaccines, actually reinforcing 
the concrete preexisting views that the intervention was designed to soften (Bloom, Marcuse, 
& Mnookin, 2014). For instance, school mandates have been shown to be effective in certain 
socio-economic circumstances, but these types of vaccination requirements do not address 
underlying concerns about hesitancy and may incur resistance due to perceived infringements 
upon civil liberties (Abrevaya & Mulligan, 2011; Omer, Salmon, Orenstein, deHart, & Halsy, 
2009; Sadaf et al., 2013; Whittle et al., 1988; Wingham et al., 2014). Some interventions 
have attempted to influence peers via social networks in order to increase vaccine uptake, but 
the effectiveness of these is limited (Betsch, Renkewitz, & Haase, 2013; F. Fu, Rosenbloom, 
Wang, & Nowak, 2010; Rubin & Landsman, 2016).  
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The evidence all suggests that vaccine hesitancy is a belief that forms after interactions with 
doctors or health care providers, and the influences of cultural and social norms (Dube et 
al., 2015). Parents gather information from medical professionals and social networks in 
order to make what they perceive as an informed decision regarding vaccine uptake. The 
influences that each of these sources can have on our vaccine decisions have been established 
by research (Betsch, Renkewitz, et al., 2013; Betsch, Ulshofer, Renkewitz, & Betsch, 2011; 
Kata, 2012; Rubin & Landsman, 2016). With the rise of the modern anti-vaccination effort, 
health care workers face increased challenges when disseminating correct information 
regarding vaccine safety, especially when many parents come into clinics with conflicting 
sources of information potentially from anti-vaccine propaganda websites (Tafuri et al., 
2014). 
Vaccine Risks And Benefits 
There is some evidence that different types of information presentation (e.g. narrative 
vs statistical information) may have differing influences on how individuals perceive vaccine 
risks. Betsch et al. (2011) compared the influence of narrative stories versus numerical and 
statistical information to examine how we incorporate external information into our decisions 
to vaccinate. They concluded that individuals who reported more vaccine-related adverse 
events show reduced intent to vaccinate (Betsch et al., 2011). They also found that narratives 
have a stronger influence on vaccination decisions than statistical information, with highly 
emotional narratives having the greatest impact (Betsch et al., 2011). Much of the currently 
available information that advocates for vaccination is numerical and statistical in nature. In 
contrast, the information that the anti- vaccine movement uses tends to be emotional in 
nature (Reyna, 2012). A fruitful area for future research and intervention may be to identify 
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emotionally laden features of pro-vaccine movements, like the ability to save defenseless 
elderly individuals and children from fatal disease via concepts like herd immunity. 
How risk perception in vaccine decisions can be more heavily influenced by 
emotional stories may be related to how we retrieve information related to risk. Reyna (2012) 
uses an idea called fuzzy-trace theory, which suggests that we create gist representations of 
our feelings about risk, and use those to inform the decision making process. Fuzzy-trace 
theory states that we take meaning from our available knowledge, experience, and prior 
beliefs, and combine it all into a final gist representation which guides our decision (Reyna, 
2012). As an example, we may read information that states that a majority of children 
vaccinated against Hepatitis B are not at risk for demyelination of the central nervous system. 
From that, we may draw that a minority of Hepatits B vaccines do result in demyelination. 
We may understand that MS involves demyelination, and draw a gist representation that 
states “some Hepatitis B vaccines result in MS”. As a result, we choose not to vaccinate 
(Reyna, 2012). The ultimate driver here is a synthesis of acquired information with prior 
beliefs and prior knowledge that may result in an overestimation of perceived vaccine risks. 
The decision to vaccine involves balancing potential benefits and risks (Henininger, 
2009; Shim & Galvani, 2012). The true risks of vaccination are relatively slight and are 
typically constrained to side effects like mild cough, fever, irritability, and diarrhea, but even 
then the rates are often similar to that of a placebo vaccine (Henininger, 2009). The 
likelihood of these very mild side effects vary widely between vaccines, but can range from 
5% (rash after MMR vaccine) to 90% (soreness at injection site for HPV vaccine) (CDC, 
2017). A small number of vaccinations do carry a risk for more severe side effects.  For 
instance, the intranasal flu vaccine has been associated with 0.54% of facial palsy (Mutsch et 
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al., 2004).  In addition to the real risks, many individuals report a perception of risks that 
have not been validated with evidence. The breadth of these perceived risks varies from 
diabetes, demyelination, autism, asthma, and sudden infant death syndrome (SIDS) (Black et 
al., 2002; DeStefano, Bhasin, Thompson, Yeargin-Allsopp, & Boyle, 2004; COID, 2004; 
Hocine et al., 2007; Stratton, Howe, & Johnston, 1994). 
The individual benefits of vaccines are directly related to immunity from disease. 
However, the efficacy of vaccines is not 100%.  Figure 1 demonstrates various metrics for 
the benefits of vaccination, from cases prevented, lives saved, to monetary savings. 
(Davidkin, Kontio, Paunio, & Peltola, 2010; de Quadros, Andrus, Olive, de Macedo, & 
Henderson, 1992; Hinman, 1999; Hull & Aylward, 2001). 
  Prevention of disease also includes reduced healthcare costs. The smallpox vaccine 
has saved over 350 million potential victims and an estimated 40 million deaths from its 
inception through 2003, and it is estimated that United States monetary savings from the 
smallpox vaccine are valued at $300 million per year (Ehreth, 2003). Conversely, Malaria 
accounts for $100 billion lost GDP in sub-Saharan Africa (Ehreth, 2003). Despite the clear 
benefits of vaccination, some individuals still perceive that risks as outweigh the value of 
improved immunity. This magnification of risk may be due in part to a conflict between 
public health strategies that benefit a population and individual choices designed to maximize 
personal health (Bauch et al., 2003; Betsch, Böhm, & Korn, 2013; Fine & Clarkson, 1986; 
Galvani, Reluga, & Chapman, 2007). 
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 Figure 1. Metrics of Vaccine Efficacy adapted from Zhou et al. (2014) 
 
 
 
Herd Immunity 
Herd immunity is the primary impetus for population wide vaccination policies 
(Francis, Jr, Salk, & Brace, 1946). Sufficient vaccination coverage throughout a population 
can effectively eliminate diseases, even without 100% coverage. Indirect protection is passed 
from vaccinated to unvaccinated individuals because the likelihood of encountering a disease 
carrier is substantially reduced (Fine, 1993). Figure 2 provides a visual example of the 
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benefits herd immunity can have. Herd immunity deserves special consideration when 
patients make vaccine decisions as it can extend the efficacy of vaccines to those who are 
unable to undergo vaccination themselves due to age or health-related conditions (Fine, 
1993). Research has investigated the necessary rates of vaccination for herd immunity in 
certain diseases like influenza, which vary from 11% to 40% during four pandemic outbreaks 
from 1918-2010.  
Herd immunity could result in the complete elimination of some diseases (Cohen, 
Brezis, Block, Diederich, & Chinitz, 2013). For example, in Japan, influenza vaccination in 
schoolchildren was shown to reduce both morbidity and mortality rates among the elderly, 
whose immune systems may not be able to properly handle vaccination (Reichert et al., 
2001). Examples such as this illustrate the indirect effects that immunity can have, 
decreasing the risk of disease transmission to more susceptible members of the population. It 
is precisely this effect on transmission of the disease that serves to drive herd immunity 
(Fine, 1993; Fine et al., 2011). 
Herd immunity has been described by medical professionals and epidemiologists since 1923 
(Topley & Wilson, 1923), but it is still largely misunderstood outside the medical 
community. When considering their primary motivations for vaccination, many parents do 
not seem to be concerned with herd immunity, disregarding the benefits associated with it 
and the effect it can have on disease eradication (Lee, Whetten, Omer, Pan, & Salmon, 
2016).  
Surprisingly, a small subset of parents even consider the term to be negative, 
associating herd immunity with the idea of a “herd mentality” (Sobo, 2016). Other  
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 Figure 2. A demonstration of herd immunity. In the high vaccination condition, the non- 
immunized individuals are protected from disease by the immunity of the surrounding 
individuals – because the level of population immunity is so great, the likelihood that they 
will come into contact with an infected person is virtually zero. 
		 86 
sentiments expressed by parents about herd immunity relate it to something unnecessary, 
illogical, and unproven (Sobo, 2016).  Fewer than 6% of parents spontaneously mention the 
concept when describing their main motivations for vaccination (Quadri-Sheriff et al., 2012). 
Research examining the role of herd immunity on vaccine decisions is decidedly limited – as 
of 2010 only 29 studies had attempted to quantify or otherwise assess how herd immunity 
may impact vaccination decisions. 
Although the concept of herd immunity is not widely understood by parents, research 
has outlined numerous indirect benefits of self-vaccination. Many studies investigating 
influenza have demonstrated the effects of herd immunity to protect elder individuals (Piedra 
et al., 2005; Plans-Rubio, 2012). A review from 2006 cites eleven studies that, taken 
together, suggest indirect protection from vaccination (Jordan et al., 2006). Vaccination of 
children induced lower rates of respiratory illness in members of the family, fewer numbers 
of prescriptions, and lower rates of antibiotic use (Esposito et al., 2003). Population-wide 
benefits can be directly seen from vaccination in children. Vaccinating 20% of children 
reduces the total number of influenza cases by 46%; vaccinating80% of children reduces 
prevalence by 91% (Weycker et al., 2005). Due in part to herd immunity, measles is very 
close to being eliminated entirely (Peltola, Jokinen, Paunio, Hovi, & Davidkin, 2008). 
While parents rarely consider herd immunity as a primary reason to vaccinate their children, 
more than 1/3rd rank herd immunity the second most important motivating factor driving 
motivation. With certain vaccine preventable diseases, this second level of motivation might 
prove more important. In some instances, there is a significant distinction between those who 
benefit most from vaccination, and those who are able to receive the vaccine. For example, 
elderly and very young infants are typically not eligible for influenza vaccines, yet they have 
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the highest risk of death from contracting the disease (Mutsch et al., 2004). As such, they 
would benefit the most from high levels of vaccine uptake (Jordan et al., 2006). When 
making a decision for or against vaccinating, especially when the disease in question is not 
particularly risky to the recipient of the vaccine, it may be beneficial to promote a prosocial 
motivation to increase vaccine uptake (Jordan et al., 2006; Reichert et al., 2001). 
Indeed, recent research suggests this to be the case. Li, Taylor, Atkins, Chapman, and 
Galvani (2016) showed that a short prompt the showcasing societal benefits of vaccination 
increases vaccine uptake. This effect was strongest among individuals who were historically 
non-vaccinators. It could be that these individuals originally downplayed disease risks, but 
being presented with a reminder about preventing disease in more vulnerable populations 
shifted their motivation to vaccinate towards helping others. Another mediating factor in this 
shift was an individual’s underlying prosociality, which accounted for a small and 
independent increase in their desire to vaccinate after receiving the messages regarding 
potential benefits to others (Li et al., 2016). 
Other research has investigated how prosocial messages may influence a by-product 
of herd immunity known as free-riding (Betsch, Böhm, et al., 2013; Heffernan & Keeling, 
2009). When faced with increased population levels of vaccination, a dichotomy arises. The 
reduced global risk of contracting vaccine preventable diseases reduces the perception of 
disease susceptibility, thereby decreasing an individual’s motivation to vaccinate. This 
reduced salience of risk can induce behavior labelled “free-riding”, where an individual 
doesn’t feel the need to vaccinate themselves because everyone around them is already 
vaccinated. In other words, the individual is freed from risk by riding the global immunity. A 
concern with promoting herd immunity is that greater knowledge of the benefits related to 
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high levels of vaccination will actually encourage people to vaccinate less as a result of 
decreased risk of disease transference and increased perception of the cost to vaccinate (time, 
money, potential side effects etc.) 
To examine this, Betsch, Böhm, et al. (2013) used two different methods of 
explaining the benefits of herd immunity. One method expressed how herd immunity can 
protect an individual from contracting a disease through indirect protection, while a second 
message highlighted the contribution that vaccinating oneself can make to protecting others 
(prosocial behavior). Messages highlighting the individual benefits of herd immunity 
promoted free-riding, while messages promoting societal benefits increased prosocial 
vaccination behaviors (Betsch, Böhm, et al., 2013). This research suggests that while free-
riding behavior can be an issue, it seems to be dependent on the type of messaging used when 
communicating herd immunity benefits. So long as the messaging used frames herd 
immunity as a population benefit, free- riding behavior is not increased. 
Game Theory, Altruism, and Vaccination Decisions 
There are a wide variety of influences that factor into a seemingly simple vaccination 
decision. There are potential costs or barriers to vaccinate, including monetary cost, potential 
risk of side effects, inability to access to proper medical care etc., as well as the obvious 
individual benefit of disease prevention (Henininger, 2009). In addition, there are many 
benefits outside of an individual, including protection conferred to family members, co-
workers, and other various members of the community that an individual may come into 
contact with. As demonstrated by research investigations, these motivations will change and 
adapt with certain circumstances, like the current level of vaccination in a population, pro 
and anti-vaccine advocacy campaigns, and disease outbreaks (Bauch & Earn, 2004; 
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Chapman et al., 2012; Ehreth, 2003; Francis et al., 1946; Hinman, 1999). In order to properly 
assess all the influences these different and competing motivations may have on an 
individual’s vaccination intentions researchers have utilized game theory to create models 
used to predict an individual’s behavior within a group context. 
Game theory is a tool within mathematics and economics used to analyze scenarios 
involving groups of individuals making inherently interdependent decisions, making it highly 
 relevant to vaccination decision-making (Von Neumann & Morgenstern, 1944). In game 
theory, the likelihood of a successful outcome is dependent on the actions of other players, so 
each player must consider the other player’s possible decisions when formulating their own 
plan of action. See Figure 3 for a very simple example of a classic game, known as the 
Prisoners Dilemma, adapted for vaccine decisions. A game describes the optimal decisions of 
the players, who may have similar, opposed, or mixed interests, and the outcomes that may 
result from these decisions. At its most basic level, game theory attempts to predict an 
individual’s behavior when their own strategy (or motivations) may be influenced or 
dependent upon the strategy of all other individuals within a population. Game theory 
produces models which state the optimal response, or choice, given a certain set of 
parameters which take into consideration the potential decisions other individuals, or players, 
may engage in (Von Neumann & Morgenstern, 1944).  
The components of these “games” include a finite set of players (more than just one 
person), a set of strategies to choose from (e.g. a person can choose to vaccinate, choose not 
to vaccinate, choose a variation of the normal vaccine administration, etc.), and a relational 
outcome, meaning the outcome a player will receive given the choices made by all other 
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Figure 3. A simple example of a vaccination game. In this very basic model, the actions of 
one player directly affect the other. Here, if one player vaccinates, and the other does not, the 
unvaccinated player is still protected via the immunity of the vaccinated player. If both 
players vaccinate, they both subjected themselves to potential side effects and incurred the 
costs related to vaccination. If neither player chooses to vaccinate, then they are both 
susceptible to disease. 
 
 
players in the game (e.g. likelihood of contracting a disease given the total population uptake 
of a vaccine) (Bai, 2016; Basu, Chapman, & Galvani, 2008; Bauch, 2005; Bauch & 
Bhattacharyya, 2012; Bauch & Earn, 2004; Betsch, Böhm, et al., 2013; Bhattacharyya & 
Bauch, 2011; Chapman et al., 2012; Manfredi et al., 2010; Reluga, 2010; Reluga & Galvani, 
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2011; Shim, Grefensetette, Albert, Cakouros, & Burke, 2012). Using this type of modelling 
allows researchers to examine how any number of factors would change the strategies used 
by an individual within a population during a vaccination decision. 
Games involving vaccination decisions generally follow a similar pattern. Typically, 
individuals are spread into three separate groups – those susceptible to infection (S), those 
infected (I) and those who have been immunized through one method or another (R) (Bauch 
& Earn, 2004). This SIR model incorporates all states that members of the population may 
find themselves in, regarding any given vaccine preventable disease. Varying the rates and 
numbers within each of these groups can influence the outcomes of the vaccine games by 
driving individuals towards or away from vaccination. For example, high (or increasing) 
rates of infected individuals may incentivize vaccination behaviors, while the inverse (low 
rates of transmission and infection) could drive behavior towards lower vaccination uptake 
(Bauch & Earn, 2004; Chapman et al., 2012). Another factor involved in these game 
theoretical models includes estimations of risk perceptions, and perceived benefits of 
vaccination. Other, more basic factors include population density, birth rates, and the 
influence disease outbreaks can have (Bai, 2016; Bauch & Earn, 2004; Betsch et al., 2011).   
Game theory provides a tool that can be used to examine the influence a host of 
factors may have on a vaccine decision. Most game theory models ultimately result in the 
generation of a so-called “Nash Equilibrium”, the strategy that yields the optimal choice 
given that all other factors remain constant. When a game is said to have reached Nash 
equilibrium, no player would benefit from switching from their current strategy to a new one. 
Although these game models are theoretical, it has been demonstrated that strategies 
observed in real populations are most likely to be a convergently stable Nash equilibrium 
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(CSNE) (Bauch & Earn, 2004). The main factor influencing which strategy elicits a Nash 
equilibrium is the expected utility of the outcome. In most vaccination decisions, the 
outcome is rather simple – one either decides to vaccinate, or refuses (Bai, 2016). 
The perceived utility for any given vaccine has been typically defined as the 
difference between perceived benefits and perceived costs related to vaccination (Bauch & 
Earn, 2004). During a vaccine decision parents consider the risk of side effects from a 
vaccine, the risk of contracting a disease, and the morbidity related to that disease. Within 
this calculation of risk is an indirect influence from other parental decisions – higher levels of 
vaccine uptake in other parents reduces the likelihood that their child will contract a disease 
without subjecting them to a vaccine (Bauch & Earn, 2004; Manfredi et al., 2010). Thus, 
game theory can be useful as a method to investigate how certain incentives or deterrents can 
influence rates and level of vaccination uptake in a population (Galvani et al., 2007; Reluga, 
2010; Reluga & Galvani, 2011). 
While research supports the notion that each vaccine scenario will involve its own set 
of risks and rewards under game theory (Bai, 2016), some commonalities related to herd 
immunity and incentives have been reported. The influence of vaccine skepticism has been 
shown to promote self-interest, and as a result pushes vaccination rates to sub-optimal levels 
for indirect protection to the population, even if vaccine uptake in vaccine confident 
individuals is near 100% (Shim, Grefensetette, et al., 2012). Likewise, increased risk related 
to vaccination (whether that be perceived risk or actual risk), drives motivation away from 
population-wide benefits and towards self-interest (Shim, Grefensetette, et al., 2012). 
Similar patterns are also seen in models that replicate pandemic spread of vaccine 
preventable disease. In these instances, vaccine hesitant individuals will wait to gather the 
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nature of vaccine safety information from early adopters, relying on herd immunity until a 
clearer picture of the risks and benefits are available, which can create high transmission 
rates if the early perception of vaccine related risks is high (Bhattacharyya & Bauch, 2011). 
Both of these scenarios have real world application, where parents have acted solely in 
perceived self-interest and withheld measles vaccines. A reduced perception of risk related to 
the disease and heightened perception of risk related to vaccine side effects drove motivation 
towards self- interest, resulting in exposure of nearly 1,000 unvaccinated children to measles 
in 2008 (Sugerman et al., 2010). Game theory has shown that it is particularly difficult to 
attain community wide protection for all individuals in cases like influenza, where the 
personal utility of vaccination is much lower for the young compared to the elderly, who 
receive more benefits from herd immunity (Galvani et al., 2007). In order to reach optimal 
levels of vaccination for herd immunity purposes some individuals will eventually be forced 
to vaccinate against their individual interest. These decisions will involve a degree of 
altruism – the individual benefits will not outweigh the personal costs, even though the 
societal benefits remain. 
Altruistic action involves decisions which carry personal risk of harm, to the benefit 
of others (Dawes, 1980; Fehr & Gachter, 2002). Vaccine decisions involve a degree of 
altruism with some unique characteristics. First, there is always a risk of side effects related 
to taking a vaccine, so at the start individuals being vaccinated must be subjected to potential 
harm. An important note here is that what matters most to these individuals is the perceived 
risk of the vaccination, in addition to other types of costs (money, time, etc.). The perception 
of risk will differ from individual to individual based on a number of factors (age, income, 
demographics, personal beliefs etc.) (Quadri-Sheriff et al., 2012). Previous epidemiological 
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game theory models suggested that self-interest is the sole motivator in human decisions, but 
more recent research is beginning to dismantle this idea (Shim, Chapman, Townsend, & 
Galvani, 2012; Vietri et al., 2012). 
Using game theory research supports that in some cases up to 25% of motivation to 
vaccinate may be accounted for by altruistic tendencies, particularly when individual costs 
are low (Shim, Chapman, et al., 2012). Perhaps not surprisingly though, game theoretical 
models of vaccination behavior suggest that total disease eradication cannot be achieved, as 
certain subsets of individuals perceive vaccine risks being greater than the risk of infection 
(Bauch & Bhattacharyya, 2012; Bauch & Earn, 2004; Bauch & Galvani, 2013). This conflict 
impacts vaccine policies, which currently do not enforce mandatory vaccination. A dilemma 
occurs where voluntary vaccination rates will not allow for herd immunity to take place, but 
mandatory vaccination policies may be rightly seen as a violation of an individual’s civil 
liberties (Bauch et al., 2003). As a result, there must be a push to vaccinate with population 
based prevention in mind, which would involve altruistic actions on the part of some 
individuals. A better 
understanding of the process underlying the role altruism plays in vaccine motivation would 
help to build programs that increase vaccine uptake to reach herd immunity levels. 
Social Distance and Discounting of Vaccine Benefits 
Underlying much of a decision to vaccinate is an analysis of the risks related to 
vaccines, compared against the benefits derived from vaccination and the immunity it may 
confer (Heininger et al., 2012; Henininger, 2009). However, as outlined with the principle of 
herd immunity, many of the benefits derived from vaccination actually take place beyond the 
person being vaccinated. Research has suggested that some indirect benefits can be seen 
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within the family and also that individuals consider benefits to those well outside of the 
family (Chapman et al., 2012; Reichert et al., 2001; Shim, Chapman, et al., 2012; Vietri et 
al., 2012). However, it follows logically that individuals may care more about the indirect 
protection vaccines can have in those socially close to them compared to those socially 
distant. 
The amount to which a person places value on the indirect protection vaccines confer 
may be something that decreases with social distance. As individuals, we tend to care more 
about the people socially proximate to us compared to those socially distant (Dawes, 1980; 
Jones & Rachlin, 2006; Jones & Rachlin, 2009; Rachlin & Jones, 2008a, 2008b; Trope & 
Liberman, 2010). Again turning to behavioral economics, models of the way individuals 
discount benefits have been created to show how we tend to decrease the value of a reward 
when it is shifted outwardly in our social network (Rachlin & Jones, 2008b). In other words, 
we place lower value on rewards that go to individuals other than ourselves.  Figure 4 
demonstrates the relationship between prosocial motivation and the recipient of benefits. 
Beginning with the principle of probability discounting as applied to health behaviors like 
vaccine decisions, we can attempt to understand the relationship between how likely an 
individual is to engage in a behavior (i.e. deciding to vaccinate), and the likelihood of that 
behavior resulting in a positive outcome (i.e. a vaccine’s efficacy, or ability to provide 
immunity) . Probabilistic discounting would suggest that an individual would be less likely to 
decide to vaccinate as a function of the likelihood that a vaccine will afford immunity, an 
idea that can be described mathematically (Green & Myerson, 2004; Rachlin, Raineri, & 
Cross, 1991). These models allow for an examination of the likelihood that an individual will 
decide to vaccinate given different likelihoods of immunity. 
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Figure 4. Hypothetical Social Discounting function. Here, you can see the quick acceleration 
of the discount function at the socially proximate levels of the decision. Overall, we are more 
willing to forego money for ourselves in order to be generous if the recipient of our 
generosity is well known to us. As social distance increases, our generosity typically 
decreases rather quickly, leveling out once social distance becomes relatively high. 
 
 
While traditional models of decision-making assume that an individual only considers 
self-interest in these probabilistic discounting decisions, research has begun to investigate 
how these types of decisions are modified when considering benefits to others as well (Jones 
& Rachlin, 2006). This idea has been termed “social discounting”, and seems particularly 
relevant to vaccine decisions as the benefits of vaccination under herd immunity are granted 
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to other members of society. At its core, social discounting incorporates the concept that the 
value we place upon a reward will change based on the recipient (Jones & Rachlin, 2006). 
Logically, as we become less familiar with the individual receiving a reward, we begin to 
place less and less value upon the reward, until the recipient is a complete stranger. Jones and 
Rachlin (2006) described the hyperbolic rate at which this discounting occurs – at first, when 
individuals are relatively close to us (parents, siblings, good friends) the rate of discounting 
the rewards they may receive from our decisions declines slowly. However, as the recipient 
approaches more distant acquaintances (second cousins, co-workers, friends of friends etc.) 
we quickly begin to discount the value placed on the rewards they may receive. 
  Typically, these social discounting paradigms measure a participant’s willingness to 
forego some sum of money, in order to give money to another individual. For example, a 
question might state “Would you rather have $150 for yourself, or $75 for you and give $75 
to a stranger?” In this example, the participant would have to forego $75 in order to give $75 
to another person. There have been many studies investigating and validating social 
discounting paradigms and factors that may influence it. Some research has shown that the 
likelihood of receiving a benefit can affect social discounting as well (Jin, Pei, & Ma, 2017). 
When payoffs were uncertain, individuals tended to act slightly more prosocial. One might 
also suspect that cultural differences could influence social discounting, and research 
supports that eastern collectivist cultures might exhibit lower levels of social discounting. 
Research by Strombach et al. (2014) support this idea, showing that Germans more quickly 
discount benefits at close social distances compared to Chinese participants. However, the 
base paradigm was stable throughout both groups, in that all participants discounted benefits 
in a hyperbolic manner as social distance increased. 
		 98 
These examples highlight some limitations of current social discounting research – 
the current models outlining social discounting are all based on an original paradigm which 
used monetary gain for self and others (Jones & Rachlin, 2006). The concept has also been 
supported in climate change, where ones actions can benefit others (Kaplan, Reed, & 
McKerchar, 2014). However, there has yet to be investigations into how social discounting 
may be modified when there is potential risk to the decision-maker. Consider vaccine 
decisions, where there is a small risk (perceived or actual) related to side effects from 
vaccination, along with benefits to oneself (immunity) and benefits to others (conferred 
immunity). The important distinction here is that there is a degree of non-reciprocal altruism 
occurring – the protection conferred from vaccinated oneself or one’s child to socially distant 
individuals is not directly reciprocated in a visible manner. It has been suggested that this 
non-reciprocal altruism is related to the hyperbolic discounting of social benefits (T. 
Takahashi, 2007). This aspect would underlie motivations in vaccine decisions as well – by 
vaccinating your children you can see the benefits to your family or friends, but not to 
strangers. 
Investigations into how these types of decisions may change when considering 
benefits to socially distant could be very useful to target interventions to increase uptake in 
vaccination. As stated in previous sections, simple interventions reminding participants of the 
general herd immunity benefits vaccines increase vaccination motivation – however these 
messages were vague and general in nature (Betsch, Böhm, et al., 2013; Chapman et al., 
2012; Li et al., 2016). It could be more impactful to state particular individuals (family 
members, friends etc.) who would receive the indirect benefits vaccines confer, as opposed to 
strangers, or member of the general public. Social discounting research shows that we care 
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much less about the benefits directed towards these unknown individuals, therefore it 
logically follows that bringing salience to the benefits of social proximate individuals may be 
more prudent when targeting vaccine advocacy campaigns. For example, if a message were 
targeted to highlight how vaccinating your child against the flu can prevent them from 
spreading the disease to their grandparents (who have a much higher mortality rate from 
influenza), it may be more impactful than a message which only reminds a participant about 
herd immunity principles. 
What this suggests is that voluntary vaccination methods will never be enough to 
sufficiently reach a population wide level of vaccination that would provide coverage to 
those individuals who most need protection such as the elderly, infants, and those unable to 
be vaccinated for medical reasons (Bauch et al., 2003). Researchers have outlined the process 
of social distance to measure just how quickly we discount reward to ourselves vs. reward to 
others (Jones & Rachlin, 2006; Jones & Rachlin, 2009; Rachlin & Jones, 2008a). By 
implementing social distance as a function of perceived benefits in vaccine decisions, it 
would be possible to estimate precisely at what point the motivation to protect socially 
distant individuals stops, in addition to the precise rate at which it decreases. Additionally, 
investigations into factors that may influence social discounting rates, like vaccine hesitancy 
or prosocial tendencies, could be conducted. These types of measurements could then be 
used to inform advocacy campaigns that specifically target certain individuals, or contain 
information that states what specific individuals in your social network you are putting at risk 
by not vaccinating. By targeting interventions that highlight individuals a person still cares 
about protecting (such as those moderately distant, but not quite strangers), we may be able 
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to motivate some individuals into vaccinating when previously they would not have chosen 
to do so. 
Conclusions 
Vaccine uptake has met resistance beginning with its conception from Edward Jenner 
and his smallpox inoculations (Plotkin, 2014; Stern & Markel, 2005). Despite many modern 
advances in vaccine safety, and the near eradication of diseases like measles, polio, and 
smallpox directly related to vaccination rates, vaccine hesitant individuals still strive to avoid 
vaccine uptake, putting the rest of the population at greater risk for these diseases (Bloom et 
al., 2014; Patel et al., 2016; Weycker et al., 2005; Whittle et al., 1988). Vaccine policy is 
unlikely to mandate vaccines, and it has been suggested that self-interest in vaccine decisions 
cannot result in full herd immunity as the perceived benefits dwindle with greater coverage 
rates (Bauch & Galvani, 2013). Advocating altruism may be necessary to achieve sufficient 
coverage for herd immunity (Fine & Clarkson, 1986; L. Y. Fu, Bonhomme, Cooper, Joseph, 
& Zimet, 2014; Shim, Chapman, et al., 2012). 
Current investigations into how to address vaccine hesitancy have been inconclusive, 
and do not suggest that any particular method has been overly effective in convincing 
hesitant individuals to vaccinate or not (Bloom et al., 2014; L. Y. Fu et al., 2014; Jarrett et 
al., 2015). Many parents who face vaccine decisions for their children are unaware or 
misinformed about the potential of vaccination to produce indirect benefits to others. Some 
research has demonstrated that this type of altruistic motivation does influence vaccination 
decisions in a prosocial manner, and further research has suggested that a simple reminder 
that vaccines do confer protection via herd immunity can have an effect on vaccine uptake 
when risk and costs are perceived low (Betsch, Böhm, et al., 2013; Betsch, Renkewitz, 
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Betsch, & Ulshofer, 2010; Chapman et al., 2012). Behavioral economic and game theory 
models can demonstrate scenarios where individuals choose to act prosocially (Jones & 
Rachlin, 2006), but less is understood about the precise mechanisms in this prosocial 
motivation. 
While there is quite a bit of evidence that altruism factors into vaccine decisions, it 
follows logically that people may consider socially distant benefits differently to people 
relatively close to them, versus complete strangers (Rachlin & Jones, 2008a; Shim, 
Chapman, et al., 2012). Future research could investigate, using social distance, how 
perceived benefits of vaccines may change as social distance increases. One could also then 
investigate whether or not factors like vaccine hesitancy or vaccine confidence changes how 
quickly individuals discount benefits of vaccines as social distance increases. This kind of 
research could serve to target interventions, for example, if it is shown that people tend to 
still perceive benefits to close family members as important, compared to more socially 
distant individuals like co- workers or friends of friends. Vaccine uptake could then be 
targeted to protect those individuals instead of the less well conceived notion of herd 
immunity and population-wide benefits. 
Vaccines have had a long history of meeting resistance, yet progress is slowly being 
made towards disease eradication. In order to achieve this end goal, investigations into how 
and why some individuals choose to be altruistic in their vaccine decisions should be made, 
as policy and history suggest that without altruism society will be unable to achieve proper 
herd immunity.  
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